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Due to the superior soft-tissue contrast of magnetic resonance imaging (MRI) compared to 
conventional computed tomography (CT) and other on-board imaging techniques, several groups have 
integrated MRI and radiation treatment machine systems. The advent of MR image-guided radiation 
therapy (MR-IGRT) using systems, such as the 1.5 MRI – 7 MV linear accelerator (MR-Linac), now 
allow for improved soft-tissue on-board imaging for patient position and tumor target localization 
verification and the ability to assess functional biological tissue characteristics with MRI, all without 
increasing the patient radiation burden. 
However, with the advantages of MRI guidance in MR-IGRT came the dosimetric challenges 
of the presence of a strong magnetic field. When the magnetic field is oriented perpendicular to the 
radiation beam, Lorentz forces act on secondary electrons causing hot and cold spots at tissue transition 
areas. These interactions with the magnetic field cause perturbations of the dose distribution in three 
dimensions. Current vendor-supplied electronic quality assurance tools can provide at best quasi-3D 
sampling of the dose distribution and cannot be MR imaged. As a result, there was a growing need for 
volumetric, MR-visible, and radiation-sensitive detectors for MR-IGRT applications. To fill this need 
for volumetric dose quality assurance, this dissertation work investigated existing and novel 
formulations of radiochromic gel dosimeters. After the optimal radiochromic gel formulation was 
identified, it was characterized for dose linearity, radiological properties, reproducibility, time stability, 
energy dependence, reusability, dose rate dependence, fractionation dependence, gel matrix 
dependence, and diffusion. Next, strong magnetic field and gradient field/radiofrequency effects on the 
vii 
 
 
 
response of 3D dosimeters were assessed along with other MR considerations that were and were not 
specific to MR-IGRT systems. Finally, heterogeneous and homogeneous 3D dosimeters were used for 
end-to-end testing with a variety of Monaco TPS plans. 
This dissertation work contributed significantly to the fields of 3D dosimetry, MR-IGRT, and 
radiation physics: the first proof of concept of real-time 2D and 3D dose acquisition during irradiation 
was presented, a novel radiochromic gel dosimeter and its reusable version were presented and 
characterized, and the first full end-to-end testing including adaptive planning using daily MR images 
of the 3D dosimeters was presented. Overall, the feasibility and benefit of MR-visible and radiation-
sensitive 3D dosimeters were presented in this dissertation work for MR-IGRT applications. 
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Chapter 1 – Introduction 
 
1.1 Integrated magnetic resonance imaging – radiation therapy systems 
Prior to delivering patient radiation treatments, conventional treatments utilize some form of 
on-board imaging technique, both to ensure the consistency of the daily overall positioning of the 
patient as well as ensuring that the tumor target is within the radiation beam path. These imaging 
techniques include on-board megavoltage (MV) and kilovoltage (kV) imagers, cone beam computed 
tomography (CBCT), CT on rails, time-of-flight (ToF) cameras, and more sophisticated combinations 
of x-rays and cameras such as the Brainlab ExacTrac® [1–12]. However, MV and kV images provide 
poor soft-tissue contrast compared to magnetic resonance imaging (MRI) and rely largely on bony 
anatomy for patient positioning, assuming that the tumor has not moved relative to the bony anatomy. 
These conventional techniques also add to the overall radiation burden of the patient, which is 
especially of concern for pediatric patients. ToF cameras and other similar techniques only utilize the 
surface of the patient, again assuming that the tumor has not moved relative to the patient skin. 
However, tumors do not always behave idealistically and are known to change shape, move due to 
surrounding organs during treatment, and move due to overall patient weight changes between 
treatment fractions [13–18]. While patient immobilization techniques are used to help mitigate set-up 
uncertainties, several of these changes cannot be controlled. These changes can occur between the time 
of CT simulation and radiation treatment, daily due to inherent patient motion such as breathing, and 
gradually throughout treatment due to patient weight changes or disease progression or shrinkage. 
Larger planning target volumes (PTVs) have been implemented to account for tumor localization errors 
at the cost of unnecessarily irradiating adjacent normal tissues and organs at risk. Attempts have been 
made to mitigate these concerns with the use of fiducials, acquiring CTs more frequently during the 
course of treatment, and breath-hold and gating techniques to account for respiratory motion. However, 
the use of MRI is superior to such methods for soft tissue targets that may not necessarily track 
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according to bony anatomy or skin surface motion without adding any radiation burden to the patient, 
and the integration of MRI has been proposed by several groups for these reasons. 
Due to the superior soft-tissue contrast of MRI compared to conventional computed 
tomography (CT) and cone-beam CT, several groups have designed integrated MRI with radiation 
treatment machine systems. These include the pre-clinical 1.5 T MRI – 7 MV linear accelerator (linac) 
(MR-Linac, Elekta, AB, Stockholm, Sweden), a prototype system combining a 1.0 T MRI with a 6 MV 
linac (Ingram Institute, Sydney, Australia), the Aurora RTTM 0.5 T magnet with 6 MV linac (MagnetTx, 
Saskatchewan, Canada), and the MRIdianTM 0.35 T magnet with cobalt-60 (Viewray, Inc., Oakwood 
Village, Ohio, USA) (Figure 1) [19–23]. Both the Elekta MR-Linac and the Viewray MRIdian consist 
of a radiation beam perpendicular to the MRI magnetic field. The Elekta MR-Linac and the Viewray 
MRIdian both orient their radiation sources (linac assembly or cobalt-60 sources) on a rotating gantry 
surrounding the MRI. The Viewray MRIdian consists of a split magnet design to allow for a lower 
source beam energy whereas the Elekta MR-Linac requires the flattening filter free (FFF) radiation 
beam to pass through the cryostat. In the Elekta MR-Linac, active magnetic shielding is used around 
the linac, and the magnet design reduces the fringe field to minimize any magnetic field effects on the 
accelerator components. The Sydney MRI-linac is designed to function with the linac component 
switching between parallel and perpendicular configurations with respect to the magnetic field. The 
MagnetTx Aurora RTTM consists of a cryogen free bi-planar rotating magnet with the linac oriented 
parallel to the MRI magnetic field. Unlike the other aforementioned systems, the MagnetTx Aurora 
RTTM is designed with concurrent rotation of the linac and MRI components. The Sydney MRI-linac 
and the MagnetTx Aurora RTTM have the advantages of positioning the radiation beam parallel to the 
MRI magnetic field, therefore reducing influences of the magnetic field on the radiation dose 
distribution. The disadvantages of the Viewray MRIdian and MagnetTx Aurora RTTM are their lower 
magnetic field strengths, 0.35 T and 0.5 T, respectively, reducing the MRI signal-to-noise ratio (SNR), 
overall image quality, and potential for advanced functional MRI techniques. However, the lower 
magnetic field strengths do have the advantage of minimal influences on electronic devices, medical 
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devices such as MR-compatible pacemakers, and simplifying dosimetry as a result of less influence on 
secondary charged particles. While the Sydney MRI-linac combines the stronger magnetic field 
strength advantage of the Elekta MR-Linac along with its dual orientation possibility, this system has 
not yet been developed into a functional product to date. For several of the mentioned reasons, the 
University of Texas MD Anderson Cancer Center obtained the 2nd worldwide and 1st North American 
Elekta MR-Linac system and is the main MR-IGRT system discussed in this dissertation work. 
 
Figure 1: Illustrations of a) the pre-clinical 1.5 T MRI – 7 MV linear accelerator (linac) (MR-Linac, 
Elekta, AB, Stockholm, Sweden) (Raaymakers BW, Lagendijk JJW, Overweg J, Kok JGM, 
Raaijmakers AJE, Kerkhof EM, van der Put RW, Meijsing I, Crijns SPM, Benedosso F, van Vulpen 
M, de Graaff CHW, Allen J, Brown KJ (2009) Integrating a 1.5 T MRI scanner with a 6 MV 
accelerator: proof of concept. Phys Med Biol 54:N229–N237. doi: 10.1088/0031-9155/54/12/N01) 
(© Institute of Physics and Engineering in Medicine.  Reproduced by permission of IOP Publishing.  
All rights reserved.), b) the 1.0 T MRI with 6 MV linac in Sydney for inline (left) and perpendicular 
(right) configurations (Keall PJ, Barton M, Crozier S (2014) The Australian Magnetic Resonance 
Imaging–Linac Program. Semin Radiat Oncol 24:203–206. doi: 10.1016/j.semradonc.2014.02.015) 
(© Seminars in Radiation Oncology.  Reproduced by permission of Elsevier.  All rights reserved.), c) 
the 0.5 T with 6 MV Aurora RTTM (MagnetTx) (Fallone BG (2014) The Rotating Biplanar Linac–
Magnetic Resonance Imaging System. Semin Radiat Oncol 24:200–202. doi: 
10.1016/j.semradonc.2014.02.011) (© Seminars in Radiation Oncology.  Reproduced by permission 
of Elsevier.  All rights reserved.), and d) the 0.35 T with cobalt-60 or linac MRIdian (Viewray, Inc.) 
(Mutic S, Dempsey JF (2014) The ViewRay System: Magnetic Resonance–Guided and Controlled 
Radiotherapy. Semin Radiat Oncol 24:196–199. doi: 10.1016/j.semradonc.2014.02.008) (© Seminars 
in Radiation Oncology.  Reproduced by permission of Elsevier.  All rights reserved.). 
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Compared to conventional on-board imaging acquired for patient position verification on a 
linac, MRI has numerous advantages: a variety of acquisition parameters and resulting image contrast 
to more accurately localize soft tissues; the ability to reflect functional biological tissue characteristics 
such as tissue oxygenation and perfusion; and the ability to image without increasing the patient 
radiation burden [24–35]. The integration of MRI with radiation treatment machine systems will 
especially benefit patients with soft tissue lesions that are more difficult to track using conventional on-
board techniques [36–38]. Encouraging preliminary patient data have been presented for pancreas and 
gastrointestinal sites using the MRIdian [39, 40]. Furthermore, the integration of MRI with radiation 
treatment machine systems is not limited to the daily advantage of patient and tumor tracking. As 
mentioned previously, MRI can provide valuable functional imaging to assess tumor morphology and 
response to radiation treatment. Predicting the radiation treatment response for each patient using 
functional MRI techniques could enable more personalized and daily adaptive treatments, therefore 
making it possible to deliver higher rates of curative treatment while minimizing normal tissue 
toxicities. MRI may be able to provide more accurate target delineation for certain tumor sites during 
treatment planning, and creating pseudo-CT data sets from only MRI are under development [41–50]. 
With the advantages of real-time MRI guidance came the dosimetric challenges of the presence 
of a strong magnetic field. The focus of this dissertation work was for the 1.5 T – 7 MV Elekta MR-
Linac. As mentioned previously, the MR-Linac system consists of a radiation beam perpendicular to 
the strong magnetic field, with the linac components mounted on a rotating gantry around the MRI 
(Figure 1). When the magnetic field is oriented perpendicular to the radiation beam, Lorentz forces act 
on secondary electrons causing hot and cold spots at tissue transition areas, such as a radiation beam 
exiting from tissue into air (Figure 2 shows Monte Carlo calculated point spread kernels of secondary 
electrons at different magnetic field strengths) [51–58]. These changes in the electrons’ trajectories in 
the magnetic field cause perturbations of the dose distribution in three dimensions throughout 
heterogeneities present in human anatomy, such as areas including the trachea and sinuses.  
Conventional quality assurance tools include point measurements using ionization chambers, 
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thermoluminscent dosimeters, and optically stimulated luminescence detectors, planar measurements 
using film or 2D arrays such as the Sun Nuclear IC Profiler and PTW Starcheck, and quasi-3D arrays 
using the Sun Nuclear ArcCHECK. Vendors are beginning to supply magnetic field-compatible quality 
assurance tools, but these can provide at best quasi-3D sampling of the dose distribution [59]. Along 
with the newfound possibility for real-time MRI during irradiation, integrated MRI with radiation 
treatment machine systems have increased the clinical interest for water-equivalent volumetric 
dosimeters. 
 
Figure 2: Monte Carlo calculated point spread kernels of secondary electrons for a) 0 T, b) 0.2 T, c) 
0.75 T, and d) 1.5 T magnetic field strengths (Raaijmakers AJE, Raaymakers BW, Lagendijk JJW 
(2008) Magnetic-field-induced dose effects in MR-guided radiotherapy systems: dependence on the 
magnetic field strength. Phys Med Biol 53:909–23. doi: 10.1088/0031-9155/53/4/006) (© Institute of 
Physics and Engineering in Medicine.  Reproduced by permission of IOP Publishing.  All rights 
reserved.). 
 
1.2 Three-dimensional dosimetry 
The introduction of using chemicals that react to byproducts of ionizing radiation in a medium 
to measure radiation dose dates back to at least 1927 when Fricke and Morse presented ferrous sulfate 
solutions [60]. Since then, such chemical formulations have been incorporated into matrixes allowing 
for volumetric or three-dimensional (3D) measurements of radiation dose (dosimeters). Currently 
existing 3D dosimeters can generally be classified into 3 categories: radiochromic gels, polymer gels, 
and radiochromic plastics. 
Radiochromic gels respond to the absorption of radiation dose by producing an optically 
readable response. The most common radiochromic gel formulations are based on Fricke and Morse’s 
works [60, 61]. The chemical foundation of formulations based on this work relies on the conversion 
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of iron(II) (ferrous, Fe2+) to iron(III) (ferric, Fe3+) due to radiolysis of water producing H·, HO·, H2, 
and H2O2 and can be described by the following equations in the presence of oxygen: 
H ·  + O2  →  HO2 ·                                                                                                (1) 
HO2 · + Fe
2+  →  HO2
− +  Fe3+                                                                          (2) 
HO2
− +  H+  ⇌  H2O2                                                                                             (3) 
Fe2+ +  H2O2  →  Fe
3+ +  HO− +  HO ·                                                           (4) 
Fe2+ +  HO · →  Fe3+ +  HO−                                                                             (5) 
giving the overall yield (G = molecules formed per 100 electron volt (eV) absorbed) of iron(III): 
𝐺(Fe3+) = 3𝐺(H ·) + 𝐺(HO ·) + 2𝐺(H2O2)                                                  (6) 
 [62]. The production of iron(III) after absorption of radiation can also be related to dose with the 
following relationship: 
Δ[Fe3+] =  
𝐷 ∙ 𝐺(𝐹𝑒3+) ∙ 10𝜌
𝑁𝐴 ∙ 𝑒
                                                                           (7) 
where D is radiation dose, ρ is the density in kg/liter, NA is Avogadro’s number (the number of units in 
one mole of any substance, 6.022 x 1023), and e is the number of Joules per eV [63]. As can be seen in 
equation (7), the dose absorbed by an irradiated Fricke gel can be directly related to the change in 
concentration of iron(III). Radiochromic gels’ response to radiation can be read out using optical or 
magnetic resonance methods. Optically, the yield or concentration of iron(III) can be related to dose 
with the following relationship: 
𝐷 =  
𝑁𝐴 ∙ 𝑒
𝜌 ∙ 𝑙 ∙ 𝐺(𝐹𝑒3+)
∙  
𝑂𝐷(𝐷) − 𝑂𝐷(0)
𝜀𝑚
                                                           (8) 
where l is the optical path length (1 cm for standard cuvettes), OD is the optical density, and εm is the 
molar extinction coefficient for iron(III) [63]. The OD of a material is related to the intensity of light 
after attenuation through the material, as explained by the Beer-Lambert Law: 
𝐼(𝜆) =  𝐼0(𝜆) ∙ 𝑒
−𝜇(𝜆)𝑥                                                                                           (9) 
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where I0(λ) is the initial light intensity for a given wavelength and μ is the linear attenuation coefficient 
(cm-1). OD can then be calculated using the following relationship: 
𝑂𝐷 =  −𝑙𝑜𝑔10(
𝐼
𝐼0
) 𝑠𝑎𝑚𝑝𝑙𝑒 𝑙𝑒𝑛𝑔𝑡ℎ⁄ = 𝑎𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒 𝑠𝑎𝑚𝑝𝑙𝑒 𝑙𝑒𝑛𝑔𝑡ℎ⁄        (10) 
where OD has the unit of cm-1. OD by definition is a measure of absorbance and includes both 
absorption and scattering of light. Transmittance, on the other hand, is equal to the final light intensity 
divided by the initial light intensity. A material will absorb light when the energy of the light matches 
the available energy states in the atoms and molecules; otherwise, the light will scatter in a different 
direction from the incident light. 
Due to paramagnetic differences between ferrous (iron(II)) and ferric (iron(III)) ions of iron, 
un-irradiated and irradiated Fricke gels can also be quantified using MR signals. The differences in the 
number of unpaired electrons and structure of complex formation for the iron ions affect the magnetic 
moment (can be simplified to spin only magnetic moment) and magnetic susceptibility of the material 
and are proportional to sqrt(n(n+2)) and n(n+2), respectively, where n is the number of unpaired 
electrons [64]. Spin-lattice relaxation rate R1 (=1/T1 where T1 is the longitudinal relaxation time) 
radiation-induced changes can be detected on MRI [60, 65–69]. The signal intensity of an MR image 
is proportional to the following relationship: 
𝑆 ∝  1 − 𝑒
−(
𝑡
𝑇1
)
                                                                                                         (11) 
where S is the signal intensity, t is time, and T1 is such that the signal decreases to 63% (or 1-e-1) of its 
initial value. The relaxation rate R1 is dose dependent and can be related to the concentration of iron(III) 
with the following equation: 
𝑅1(𝐷) =  {(𝑟𝑒𝑓𝑓
3+ − 𝑟2+) ∙ 𝐺(𝐹𝑒3+) ∙
10𝜌
𝑒 ∙ 𝑁𝐴
} ∙ 𝐷 + 𝑅1(0)                                (12) 
where R1(0) is the relaxation rate of the un-irradiated dosimeter, r3+ is the relaxation enhancement 
parameter (or relaxivity) for iron(III) and r2+ is the relaxivity for iron(II) [63]. The relaxivity for iron(III) 
is an effective relaxivity since it is dependent on the gel matrix that in turn, affects the complex 
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formation and hydration of iron(III). The relaxivities in relation to the dipole-dipole interactions (both 
scalar and dipolar coupling between nuclear and electron spins) in the material between water proton 
nuclear spins and paramagnetic ions were mathematically described under Solomon-Bloembergen-
Morgan (SBM) theory of relaxation [70–72]. The gyromagnetic ratio of electrons is larger than that of 
the hydrogen proton, resulting in a quadratically larger interaction between an electron in the iron ion 
and the proton versus the interaction between two protons. The unpaired electrons of any paramagnetic 
material cause fluctuations in the local magnetic field, resulting in changes to the relaxivities. The SBM 
theory has since been expanded upon, such as using the Lipari-Szabo correction, the modified Florence 
approach, and the Swedish slow-motion theory to further explain paramagnetic related relaxivities [73–
77]. While this explicit relationship in equation (12) is only true for iron(II) and iron(III) in solution 
and the relaxation models become more complex in a gel matrix, equation (12) still holds true for Fricke 
gels incorporated into any gel matrix as the new spin environments are incorporated through the 
relaxation rate of the un-irradiated dosimeter R1(0) [63]. The linear relationships between R1 and 
radiation dose and MR signal intensity (arbitrary unit) and radiation dose have previously been 
reported, and equation (12) can be rearranged to more clearly demonstrate the relationship between net 
R1 and dose:  
𝐷 =
𝑁𝐴 ∙ 𝑒
10𝜌 ∙ 𝐺(𝐹𝑒3+)
 ∙
𝑅1(𝐷) − 𝑅1(0)
𝑟𝑒𝑓𝑓
3+ − 𝑟2+
                                                                 (13) 
[78–81]. Using an MRI system, the R1(D) or T1(D) values can be calculated using a series of sequences, 
the gold standard being inversion recovery. The MR signal as a function of T1 can be expressed as the 
following from Bloch equation derivations: 
𝑆 = 𝑘 ∙ [𝐻] ∙ (1 − 2𝑒−𝑇𝐼 𝑇1⁄ + 𝑒−𝑇𝑅 𝑇1⁄ )                                                              (14) 
where k is a scaling factor, [H] is the proton spin density, TI is the inversion time, and TR is the 
repetition time (time interval that inversion recovery sequence is repeated). However, these sequences 
can take upwards of 20 minutes for a single slice using the inversion recovery methodology, during 
which time the iron ions would be diffusing. While faster techniques exist, including Look-Locker and 
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Modified Look-Locker Imaging (MOLLI), these were not yet available on the MR-Linac system at the 
time of this dissertation work. Since the goal of this dissertation work was to identify and develop a 
suitable volumetric gel for MR-IGRT and to demonstrate the proof of concept of applying the gel to 
MR-IGRT systems, the signal intensities from T1-weighted images were used rather than acquiring a 
long series of MR images to quantitatively calculate R1 or T1 values. As previously mentioned, both 
the linear relationships between R1 and radiation dose and MR signal intensity (arbitrary unit) and 
radiation dose have been reported for iron-based Fricke-type gels [78–81]. The iron-containing Fricke 
gels also produce a multi-exponential change in spin-spin relaxation rate R2 (=1/T2 where T2 is the 
transverse decay time) to radiation; the R2 responses of Fricke gels are not typically used for radiation 
dose assessment due to this more complex and smaller magnitude relationship [82]. The signal intensity 
of an MR image is proportional with the following relationship: 
𝑆 ∝  𝑒
−(
𝑡
𝑇2
)
                                                                                                                 (15) 
where S is the signal intensity, t is time, and T2 is such that the signal decreases to 37% (or e-1) of its 
initial value. The more complex quantification of R2 in comparison with dose for Fricke gels required 
dividing the relaxation rate behaviors into multiple parameters since multiple proton species (bulk 
water, bound water, tightly bound proton species, and other gel attributed hydroxyl groups) were 
required to explain this relaxation in Fricke gels [82]. The original Fricke gels have been modified with 
the addition of reporter compounds, most notably xylenol orange, producing Fricke xylenol orange gels 
(FXG), and exploration of gel matrixes outside of gelatin [63, 67, 83–85]. Reporter compounds or 
chelators are organic chemicals that form two or more coordination bonds with iron ions and improve 
the stability of spatial dose distribution by reducing the diffusion of iron ions. Historically, the main 
limitation of the Fricke-type gels was the diffusion of the small iron ions in the gel post-irradiation, 
degrading the dose distribution, even with the addition of reporter compounds. 
Polymer gels date back to at least 1954 with Alexander’s use of polymethylmethacrylate [61]. 
Whereas Fricke-type radiochromic gels depend on the conversion of iron ions, polymer gels depend on 
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the crosslinking of monomers forming polymers induced by free radicals produced by the radiolysis of 
water [86–89]. The polymer gel BANG® (N,N’ – methylene – bis – acrylamide (BIS), acrylamide, 
nitrogen, and gelatin) dosimeter has been simulated in the Viewray system to show good agreement 
between Pinnacle treatment planning system calculated doses and simulated 3D doses from the 
BANG® gel [59]. The measured 3D doses from BANG® and other polymer gels are dependent on 
spin-spin relaxation rate R2 (=1/T2) radiation-induced changes due to polymerization of monomers 
inside the gel [88]. However, polymer gels require toxic chemicals and an oxygen free environment 
and have demonstrated energy and dose rate dependence as well as other undesirable characteristics 
[88, 90–95]. 
Unlike both the radiochromic and polymer gels, radiochromic plastics do not depend on the 
radiolysis of water. This most recent class of 3D dosimeters first presented in 2003 consists of a non-
water soluble leuco-dye that is dissolved in a halogenated hydrocarbon, such as chloroform, and 
contained in a polyurethane plastic or silicone matrix [96–100]. Instead of water, radiochromic plastic 
dosimeters depend on the free radical byproducts of the radiolysis of halogenated hydrocarbons, 
resulting in the oxidation of the leuco dyes. Radiochromic plastic dosimeters do not require a container 
but cannot be imaged using MRI. Radiochromic plastic dosimeters require an optical read-out technique 
such as an optical computed tomography (optical-CT) device [89, 101–107]. While radiochromic 
plastic dosimeters cannot be read-out using MRI, their preservation of signal with minimal diffusion 
has allowed for remote dosimetry of the Viewray system demonstrating agreement with generated plans 
[108–110]. 
Previously, Fricke-type dosimeters were not favored for clinical quality assurance practices 
due to a faster rate of diffusion compared to polymer gels. However, with the MR-Linac and other MR-
IGRT systems, Fricke-type dosimeters can now be imaged in real-time during irradiation and 
immediately post-irradiation without moving the dosimeters to a separate MRI or optical scanner [111–
114]. Fricke-type gels are easier to make in-house compared to polymer gels, which require a hypoxic 
environment and toxic chemicals. While Fricke-type gels cannot be completely containerless like 
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radiochromic plastic dosimeters (which have no MR-visible response), they can fill any shaped molds 
allowing for the possible inclusion of heterogeneous components. As a result, this dissertation revisited 
Fricke-type dosimeters for MR-IGRT applications. And as mentioned previously, since the goal of this 
dissertation work was to identify and develop a suitable volumetric gel for MR-IGRT and to 
demonstrate the proof of concept of applying the gel to MR-IGRT systems, the signal intensities from 
T1-weighted images were used rather than acquiring a long series of MR images to quantitatively 
calculate R1 or T1 values. 
 
1.3 Outline of the dissertation 
The purpose of this dissertation was to investigate volumetric, MR-visible, and radio-sensitive 
detectors for dosimetry and quality assurance for integrated MR radiation therapy systems. The MR-
IGRT system used for this dissertation was the 1.5 T – 7 MV Elekta MR-Linac. However, the work in 
this dissertation are relevant and can be translated to any other existing MR-IGRT system. 
Chapter 2 investigates candidate volumetric gel formulations, both those already presented in 
the literature and novel formulations explored for this dissertation, for dosimetric value on MR-IGRT 
systems. This dissertation solely investigated radiochromic type volumetric dosimeters and primarily 
those based on iron. The optimal formulation for MR-IGRT applications was identified. 
Chapter 3 presents the characterization of the optimal radiochromic gel formulation identified 
in Chapter 2. Dose linearity, radiological properties, reproducibility, time stability, energy dependence, 
reusability of a formulation, dose rate dependence, fractionation dependence, gel matrix dependence, 
and diffusion were quantified. 
Chapter 4 investigates strong magnetic field and gradient field/radiofrequency effects on the 
response of the optimal radiochromic gel formulation as well as optimization of MR sequences for the 
purposes of real-time imaging during irradiation and immediate post-irradiation imaging for volumetric 
dose quantification. Other MR considerations that are true for any MRI read-out technique, such as 
MRI artifacts, are also discussed. 
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Chapter 5 examines the performance of the optimal radiochromic gel formulation as an end-
to-end quality assurance device both in heterogeneous and homogeneous phantoms for 3D plans and 
step-and-shoot intensity-modulated radiation therapy (IMRT) commissioning plans. Irradiations were 
completed alongside the quasi-3D ArcCHECK-MR QA system. 
A summary and general discussion of the unique contributions of this work are presented in 
Chapter 6. 
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Chapter 2 – Comparison of radiochromic systems for MR-IGRT applications 
 
2.1 Rationale 
With the advent of MR-IGRT systems, interest in 3D gel dosimeters has grown [108–126]. In 
particular, polymer gels have gained popularity over radiochromic gels due to the high diffusion rate 
of radiochromic gels. With the new possibility for real-time and immediate post-irradiation MRI in an 
MR-IGRT system, I revisited already existing radiochromic gel formulations and proposed new ones 
created in-house for MR-IGRT applications. Due to the timeline of this dissertation, some irradiations 
were conducted in clinical conventional linacs, using a Cobalt-60 (Co-60) source, or an orthovoltage 
x-ray unit (Philips RT-250) when the Elekta MR-Linac was not available. All irradiations in the MR-
Linac were conducted following an initial calibration of the MR-Linac. Consequently, the doses given 
are approximate but are within 5% of the dose determined at a subsequent full calibration. Calibration 
of the MR-Linac was done following IAEA TRS-398 guidelines [127]. TRS-398 used the tissue 
maximum ratio (TMR), a special case of tissue phantom ratio (TPR), with a source to axis distance 
(SAD) set-up unlike the requirement of percent depth dose (PDD) measurements with a source to 
surface distance (SSD) set-up in the AAPM TG-51 protocol. The use of TMR was preferred over PDD 
due to the preservation of the ratio of dose per incident photon at 10 cm and 20 cm depths with and 
without a 1.5 T B0 field whereas the PDD curve behavior is different in a 1.5 T B0 field (maximum dose 
is at a shallower depth than with no B0 field for example) [55]. The calibration of the MR-Linac was 
conducted using an MR-compatible Standard Imaging Exradin A1SL ionization chamber and cross-
verified using a PTW Farmer chamber with both measurements in modified MR-compatible water 
tanks. For this dissertation work on relative dosimetry, the exact dose is not necessary to demonstrate 
the proof of concept of dose-response and other characteristics. For all irradiations, a control sample of 
each dosimeter was either an un-irradiated region of the dosimeter or an un-irradiated cuvette that was 
exposed to the same environment as the irradiated samples (except for receiving radiation). 
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2.2 Iron(II) oxidation gel formulations 
 Based on the conventional FXG formulation, three additional iron(II) sources were compared 
with the conventional FAS iron(II) source to determine differences in optical and MR contrast. 
 
2.2.1 Dosimeter fabrication 
Radiochromic dosimeters consist of a radiochromic reporter component, free radical source, 
solvent, iron source, and a gelling agent. Four iron(II) oxidation gel formulations were investigated, 
referred to as FXG, FOX (ferrous oxide – xylenol orange), FCX (ferrous chloride – xylenol orange), 
and FPX (ferrous phthalocyanine – xylenol orange) with the compositions outlined below. Iron(III) 
binds to xylenol orange (reporter component) with a 1:1 ratio forming a purple complex. To improve 
uniform mixing, the iron source was added to the solvent before the reporter component. All samples 
were prepared in a low-light area to prevent extraneous environmental exposure prior to irradiation. All 
gel samples were prepared approximately 24 hours prior to irradiation to allow for gel solidification. 
The conventional FXG formulation consisted of xylenol orange disodium salt, deionized water, 
and ammonium iron(II) sulfate hexahydrate (or ferrous ammonium sulfate) (Sigma-Aldrich) (Table 1). 
The FXG formulation was modified from the original Fricke formulation by adding xylenol orange and 
was included as a comparison to the other three newly developed formulations [60, 84]. A small amount 
of sulfuric acid (Sigma-Aldrich) was added to stabilize the formulation. The FXG formulation in gel 
was prepared using 300 bloom gelatin from porcine skin. 75-80% of the total water volume was used 
to first dissolve gelatin. The gelatin mixture was heated to at least 40 ºC then cooled to 25 ºC prior to 
adding the concentrated chemical solution containing the reporter component and iron source. The gels 
were then stored at 4 ºC then acclimated to room temperature prior to irradiation. 
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Table 1: Chemical components of FXG formulation. 
Component Chemical formula Concentration 
Xylenol orange disodium salt C31H30N2Na2O13S 0.05 mM 
Water H2O ~96 wt % 
Ammonium iron(II) sulfate hexahydrate (NH4)2[Fe(SO4)2]•6H2O 1 mM 
Sulfuric acid H2SO4 50 mM 
Gelatin (C17H32H5O6)x 4 wt % 
 
 The FOX formulation consisted of xylenol orange disodium salt (Sigma-Aldrich), deionized 
water, and iron(II) oxide (Sigma-Aldrich) (Table 2). The same gel procedures described for FXG were 
used for the FOX, FCX, and FPX formulations. 
Table 2: Chemical components of FOX formulation. 
Component Chemical formula Concentration 
Xylenol orange disodium salt C31H30N2Na2O13S 0.05 mM 
Water H2O ~96 wt % 
Iron(II) oxide FeO 1 mM 
Sulfuric acid H2SO4 50 mM 
Gelatin (C17H32H5O6)x 4 wt % 
 
 The FCX formulation consisted of xylenol orange disodium salt (Sigma-Aldrich), deionized 
water, and iron(II) chloride (Sigma-Aldrich) (Table 3). 
Table 3: Chemical components of FCX formulation. 
Component Chemical formula Concentration 
Xylenol orange disodium salt C31H30N2Na2O13S 0.05 mM 
Water H2O ~96 wt % 
Iron(II) chloride FeCl3 1 mM 
Sulfuric acid H2SO4 50 mM 
Gelatin (C17H32H5O6)x 4 wt % 
 
The FPX formulation consisted of xylenol orange disodium salt (Sigma-Aldrich), deionized 
water, and iron(II) phthalocyanine (Sigma-Aldrich) (Table 4). 
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Table 4: Chemical components of FPX formulation. 
Component Chemical formula Concentration 
Xylenol orange disodium salt C31H30N2Na2O13S 0.05 mM 
Water H2O ~96 wt % 
Iron(II) phthalocyanine C32H16FeN8 0.1 mM 
Sulfuric acid H2SO4 50 mM 
Gelatin (C17H32H5O6)x 4 wt % 
 
2.2.2 Optical methods 
Samples of gel were prepared in standard size cuvettes with an optical path length of 1 cm 
(Fisher Scientific) for optical read-out. The optical density (OD, unit cm-1, as explained above in 
Chapter 1 as absorbance/sample length in equation (10)) of the gel was read-out with wavelengths in 
the visible range of the spectrum using a GENESYS™ 10S UV-VIS spectrophotometer (Thermo 
Scientific). The spectrophotometer outputs an absorbance value, and with the use of 1 cm dimension 
standard cuvettes, absorbance can directly be related to OD as absorbance = OD (cm-1). The net OD 
was calculated by subtracting the OD value of un-irradiated samples from that of irradiated samples for 
each wavelength. The standard deviation of repeat spectrophotometer measurements for a single 
cuvette was no more than 0.004 OD with up to 30 repeat readings, as will be shown in Chapter 3 (Figure 
27). While the overall goal of this dissertation was for MR-IGRT applications, access to the MR-Linac 
was not available at the beginning of this work, and access to a clinical MRI system was not possible 
within the timeframe of irradiations using clinical radiation therapy machines. Also, the standard 
deviation of 30 consecutive spectrophotometer measurements was no more than ±0.5% of the mean 
OD, a much smaller uncertainty than might be expected from measurements of MR signal intensity (up 
to ±10% standard deviation from the mean MR signal). For these reasons, any investigations that 
required low signal read-out uncertainty to assess the performance of the dosimeter used optical 
absorbance measurements instead of MR signal intensities (for example, B0 field dependence and others 
later described in Chapter 3). 
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2.2.3 Magnetic resonance methods 
All gels were contained in polyethylene terephthalate (PET) plastic containers (PAPER 
MART™) for irradiation and MR imaging. For the iron comparison portion of the study, all gels were 
contained in a 45 mm diameter cylindrical PET container. 
The radiation isocenter and MR isocenter of the pre-clinical MR-Linac system are located 
143.5 cm from the linac target and are approximately 14.3 cm above the surface of the couch (the couch 
has no vertical motion in the pre-clinical system). The center of each gel was positioned close to 
isocenter distance (within 5 mm). For the iron comparison portion of the study, the 45 mm diameter 
gels were positioned on top of 12.2 cm of water-equivalent plastic backscatter material. No build-up 
material was added on top of the gels since measurements were taken at the central cross-section of the 
gels and this was an initial investigation to compare radiation sensitivities. These gels were imaged 
with a balanced fast field echo (bFFE) sequence of repetition time/echo time (TR/TE) = 5/2.4 ms during 
irradiation and a T1-weighted turbo spin echo (TSE) sequence of TR/TE = 500/20 ms pre-irradiation 
and post-irradiation. The real-time temporal resolution was 275 ms for a single slice per acquisition. 
All images were acquired with 5 mm slice thickness using a body coil. For all of the real-time 2D MR 
images, a resolution of 1.17 pixels per mm with pixel size of 0.86 x 0.86 mm2 and field of view of 
328.56 x 328.56 mm2 were used. 
 
2.2.3 Iron(II) oxidation results and discussion 
The physical dosimeters, snapshot of the real-time acquisition, and post-irradiation 
(approximately 17 Gy) images of the four iron compounds investigated (A – FOX, B – FCX, C – FPX, 
and D – FXG) are shown in Figure 3. 
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Figure 3: a) Pictures of physical dosimeters where A – FOX, B – FCX, C – FPX, and D – FXG. The 
top half of each gel was not irradiated, and the bottom half was irradiated to approximately 17 Gy. b) 
Snapshots of bFFE acquisitions with TR/TE = 5/2.4 ms. c) Post-irradiation acquisitions with TSE 
TR/TE = 500/20 ms. MR images shown with color instead of grayscale to emphasize contrast. 
 
As shown in Figure 3, B – FCX and D – conventional FXG responded to irradiation, both 
optically and MRI. In contrast, C – FPX showed minimal MR change after irradiation. The real-time 
net change in MR signal is shown in Figure 4. The relative MR signal intensity was plotted from a 
region of interest taken within the irradiated region of each dosimeter, demonstrating a near-linear 
change with dose delivered constantly over time (R2 = 0.93 to 0.97). The relative MR signal intensity 
was calculated for each dosimeter by dividing all net signal intensities (irradiated signal intensity – un-
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irradiated signal intensity) by the net signal intensity at the time beam was turned off (225 s). The error 
bars in Figure 4 represent the propagated standard deviation from the regions of interest measured 
within the irradiated region and outside the irradiated region in each dosimeter. 
 
Figure 4: Relative MR signal intensities during real-time acquisition of a) FOX, b) FCX, c) FPX, and 
d) FXG. The orange shaded regions indicate beam-on times. Linear fits in the beam-on sections are 
also indicated. The error bars in Figure 4 represent the propagated standard deviation from the 
regions of interest measured within the irradiated region and outside the irradiated region in each 
dosimeter. 
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Unlike visual inspection of the gels’ optical and MRI response, real-time relative MR signal 
intensity plots demonstrated that a) FOX and d) conventional FXG were similar in terms of slope and 
linearity. Again, c) FPX showed minimal MR change during and after irradiation (slope during 
irradiation was -0.0005 relative MR signal intensity/time). The significant result of this first 
demonstration of 2D real-time dose acquisition with iron-based gels (except for c) FPX) in the MR-
Linac was that the real-time relative MR signal intensity change was linear with respect to time and 
therefore dose with a constant dose rate of approximately 540 ± 10 cGy/minute (R2 = 0.928, 0.967, and 
0.962 for a) FOX, b) FCX, and d) FXG, respectively). This result indicated that the conversion of 
iron(II) to iron(III) due to free radicals produced from irradiation of water molecules occured quickly 
enough to capture their production in real-time in MR-IGRT systems [62]. The overall net percent 
signal intensity increases in real-time were 24.4±10%, 21.0±5%, 3.1±5%, and 22.2±6% for a) FOX, b) 
FCX, c) FPX, and d) FXG, respectively (Figure 4). The net percent signal intensity increases from the 
post-irradiation T1-weighted images were 47.1±2%, 32.7±1%, 6.3±1%, and 32.2±1% for a) FOX, b) 
FCX, c) FPX, and d) FXG, respectively (Figure 3). 
FOX and FXG were further compared optically after irradiations using a Co-60 source (Figure 
5). The Co-60 doses were calculated accounting for exponential decay of the source and PDD using 
BJR Supplement 25 depending on the SSD, depth of measurement, and field size [128]. Complete 
spectra were acquired for several different dose levels, and the dose responses at each of the two peaks 
observed with both gels were evaluated. The optical results for FOX and FXG again agreed that FOX 
was more sensitive to megavoltage irradiation when compared to FXG at both of their respective 
spectral peaks. The optical calibration curves for FOX and FXG were fit linearly (R2 = 0.98 to 1.00) at 
their spectral peaks of 430 nm and 585 nm for FOX and 445 nm and 585 nm for FXG. Since the control 
measurements of 0 Gy were included in the linear fit calculation, the fits were not forced to intercept at 
0. 430 nm and 445 nm are both near the wavelengths absorbed for an observed color of yellow. 585 nm 
is near the wavelengths absorbed for an observed color of purple. As the irradiated dosimeters undergo 
an optical color change from yellow to purple after iron(III) forms a complex with xylenol orange, the 
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contribution of yellow decreases while the contribution of purple increases (therefore the signal at 430 
nm and at 445 nm for FOX and FXG, respectively, decrease while the opposite is true at 585 nm). The 
optical spectra and spectral peaks differ between FOX and FXG due to their different chemical 
contributions of iron, resulting in differences in the absorbance of light. The calibration curves for FOX 
were 114% and 54% greater for the yellow and purple spectral peaks, respectively, compared to FXG. 
The error bars in the calibration curves were smaller than the symbols and represented the standard 
deviation of three spectrophotometer readings per sample. Uncertainties due to batch (within and 
between) variabilities were further investigated for FOX only in Chapter 3 (Figure 26). 
 
Figure 5: Optical response of FOX and FXG. a) Spectral response of FOX, b) linear optical response 
of FOX at spectral peaks of 430 nm and 585 nm (R2 = 0.9944 and 0.9978, respectively), c) spectral 
response of FXG, and d) linear optical response of FXG at spectral peaks of 445 nm and 585 nm (R2 
= 0.9930 and 0.9844, respectively). The error bars in the calibration curves were smaller than the 
symbols and represented the standard deviation of three spectrophotometer readings per sample. 
 
The overall comparison of the four iron types demonstrated that the FOX formulation was the 
best candidate from the iron(II) oxidation formulations for future MR-IGRT studies. The FOX 
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formulation demonstrated greater optical and MR contrast when compared to the other iron(II) 
oxidation formulations (up to 114% greater optical response, 10% greater real-time MR response, and 
46% greater post-irradiation T1-weighted MR response when compared to conventional FXG). 
All of the above iron(II) oxidation formulations were then tested using sodium thiocyanate as 
the reporter compound instead of xylenol orange to investigate changes in optical and MR contrast. 
These four iron(II) oxidation gel formulations were referred to as FASST (ferrous ammonium sulfate 
– sodium thiocyanate), FOST (ferrous oxide – sodium thiocyanate), FCST (ferrous chloride – sodium 
thiocyanate), and FPST (ferrous phthalocyanine – sodium thiocyanate) with the compositions the same 
as FXG, FOX, FCX, and FPX except for replacing 0.05 mM xylenol orange with 1.0 mM sodium 
thiocyanate. Sodium thiocyanate formed a red complex in the presence of iron(III) due to the formation 
of [Fe(SCN) · (H2O)5]2+ while remaining colorless clear in the presence of iron(II) (Figure 6). 
 
Figure 6: Sample of FCST in solution (without gelatin) with a) un-irradiated iron(II)-containing 
sample and b) approximately 40 Gy irradiated iron(III)-containing sample using Co-60 source 
showing color change from a) colorless to b) blood red characteristic of thiocyanate indicators in the 
presence of iron(III). 
 
Unlike xylenol orange, using sodium thiocyanate did not result in any MR changes when 
irradiated to the same doses, suggesting that the sensitivity of this formulation was inadequate for 
conventional radiation therapy dosimetry (Figure 7). The optical changes were also minimal for this 
dose range, so again, the FOX formulation remained the ideal candidate for further MR-IGRT 
applications. The net percent signal intensity increases from the post-irradiation T1-weighted images 
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were 6.1±2%, 6.9±1%, 4.6±2%, and 6.0±2% for a) FOST, b) FCST, c) FPST, and d) FASST, 
respectively. In the future, other thiocyanate compounds and their interactions with gelling agents could 
be investigated for improved optical and MR changes post-irradiation. 
 
Figure 7: a) Pictures of physical dosimeters where A – FOST, B – FCST, C – FPST, and D – FASST. 
The top half of each gel was not irradiated, and the bottom half was irradiated to approximately 17 
Gy. b) Snapshots of bFFE acquisitions with TR/TE = 5/2.4 ms. c) Post-irradiation acquisitions with 
TSE TR/TE = 500/20 ms. MR images shown with color instead of grayscale to emphasize contrast. 
 
2.3 Iron(III) reduction gel formulations 
The rationale for investigating iron(III) reduction gel formulations was due to the instability of 
iron(II) oxidation gels (such as shown by the already oxidized purple FXG and FCX gels prior to 
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irradiation) (Figure 3) and due to previous studies suggesting slower diffusion [129, 130]. The overall 
iron(III) reduction gel fabrication, irradiation set-up, and MRI techniques were the same as those listed 
above for the iron(II) oxidation gel formulations. One already existing iron(III) reduction formulation 
was assessed (Turnbull blue (TBG)) along with two additional iron(III) sources. 
The TBG formulation was created based on photography film processing reactions [131–133]. 
The Turnbull blue or Prussian blue color was formed during the cyanotype process first invented by 
John Frederick William Herschel.  The TBG formulation consists of potassium ferricyanide, iron(III) 
chloride, and iron(III) ammonium citrate. After irradiation, organic free radicals are created and reduce 
iron(III) to iron(II), which then interact with potassium ferricyanide (red prussiate of iron), ultimately 
forming the dye Turnbull blue or Prussian blue by following two possible pathways: 
Fe3+  +  ℎ𝑣, H2O →  Fe
2+                                                         (7) 
Fe2+  +  [𝐹𝑒(𝐶𝑁)6]
3− → 𝑭𝒆[𝑭𝒆(𝑪𝑵)𝟔]
−                              (8) 
[𝐹𝑒(𝐶𝑁)6]
3− + ℎ𝑣, H2O → [𝐹𝑒(𝐶𝑁)6]
4−                             (9) 
Fe3+  +  [𝐹𝑒(𝐶𝑁)6]
4− → 𝑭𝒆[𝑭𝒆(𝑪𝑵)𝟔]
−                                 (10) 
with the iron(III) components in orange and the iron(II) components in blue and the Turnbull blue 
Fe[Fe(CN)6]- product in bold font. 
Several different combinations of concentrations of the chemical components in TBG were 
presented by previous studies, and the formulation listed in Table 5 was found to be the most sensitive 
to megavoltage irradiation [129, 130, 134, 135]. Initial investigations of TBG were done in solution 
(no gelling agent). 
Table 5: Chemical components of TBG formulation. 
Component Chemical formula Concentration 
Potassium ferricyanide K3Fe(CN)6 1.5 mM 
Iron(III) chloride FeCl3 0.45 mM 
Iron(III) ammonium citrate C6H807 · FeNH3 1.5 mM 
Water H2O ~97-100 wt % 
Hydrochloric acid HCl 5 mM 
Gelatin (C17H32H5O6)x 0-3 wt % 
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The FT (ferric chloride – triphenylamine) formulation consisted of iron(III) chloride (Sigma-
Aldrich), triphenylamine (Sigma-Aldrich), and chloroform (Sigma-Aldrich) (Table 6). The FT 
formulation was only investigated in solution form due to using chloroform as the solvent. Future work 
could investigate the FT formulation in micelle form in a gelatin-based gel. After iron(III) is converted 
to iron(II), it forms a complex with triphenylamine that appears green. 
Table 6: Chemical components of FT formulation. 
Component Chemical formula Concentration 
Iron(III) chloride FeCl3 2 mM 
Triphenylamine (C6H5)3N 81 mM 
Chloroform CHCl3 ~100 wt % 
Hydrochloric acid HCl 276 mM 
 
The FO (ferric ammonium oxalate – o-phenanthroline) formulation consisted of iron(III) 
ammonium oxalate trihydrate (Sigma-Aldrich), o-phenanthroline or 1,10-phenanthroline (Sigma-
Aldrich), and water (Table 7). o-phenanthroline must first be dissolved in ethanol before combining 
with the other chemical components. After iron(III) is converted to iron(II), it forms a complex with o-
phenanthroline that appears red with a 1:3 ratio. 
Table 7: Chemical components of FO formulation. 
Component Chemical formula Concentration 
Iron(III) ammonium oxalate 
trihydrate 
(NH4)3[Fe(C2O4)3] 
· 3H2O 
28 mM 
o-phenanthroline C6H807 · FeNH3 26 mM 
Ethanol C2H6O 5 wt % 
Water H2O ~91 wt % 
Sulfuric acid H2SO4 17 mM 
Gelatin (C17H32H5O6)x 4 wt % 
 
2.3.2 Iron(III) reduction results and discussion 
The TBG formulation responded linearly optically (OD) with respect to Co-60 dose at its 
spectral peak of 690 nm. 690 nm is within the absorbed wavelength range for an observed color of 
green/blue. However, this optical response was not immediately linear and took at least 72 hours to 
develop (Figure 8). The appearance of an offset in the dose response curve even after 72 hours may be 
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due to a gradual darkening of the gel with time following preparation, rather than a nonlinearity of 
response at low dose levels. The error bars in the calibration curve were smaller than the symbols and 
represented the standard deviation of three spectrophotometer readings per sample. 
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Figure 8: Post-irradiation response of TBG in solution (no gelatin). a) Pictures of TBG irradiated to 
0, 5, 10, 20, 40, and 60 Gy using a Co-60 source immediately post-irradiation, 3 hours post-
irradiation, and 72 hours post-irradiation. b) Spectral response of TBG 72 hours after irradiation. c) 
Calibration curve of TBG 72 hours after irradiation at the spectral peak 690 nm. The error bars in 
the calibration curve were smaller than the symbols and represented the standard deviation of three 
spectrophotometer readings per sample. 
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The TBG formulation was then tested in the MR-Linac in 2 wt % and 3 wt % gelatin to 
investigate whether any MR contrast could be detected after approximately 30 Gy (Figure 9). TBG in 
2 wt % gelatin showed an increase in MR signal intensity of approximately 0.6% post-irradiation of 
approximately 30 Gy. TBG in 3 wt % gelatin showed an increase in MR signal intensity of 
approximately 5.1% after absorbing the same dose of 30 Gy. Due to the delayed optical dose response 
over time (Figure 8) and the minimal MR changes post-irradiation (Figure 9), the TBG formulation 
was not further investigated for MR-IGRT applications. 
 
Figure 9: MR images of TBG. a) TBG in 2 wt % gelatin pre-irradiation, b) TBG in 2 wt % gelatin 
post-irradiation of approximately 30 Gy, c) TBG in 3 wt % gelatin pre-irradiation, and d) TBG in 3 
wt % gelatin post-irradiation of approximately 30 Gy. 
 
While the TBG formulation was not found to be useful for MR-IGRT applications, future 
investigations of TBG could involve incorporating it into gel matrixes other than gelatin as an 
ultraviolet (UV) light dosimeter (Figure 10). A preliminary evaluation of the response of TBG to UV 
exposure demonstrated that a visible optical response took place following exposure when incorporated 
into different matrixes (sodium polyacrylate ball and powder and Encapso® K rubber) (Figure 10). 
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Figure 10: a) TBG incorporated into sodium polyacrylate ball prior to UV exposure, b) TBG post UV 
exposure, c) TBG incorporated into sodium polyacrylate powder prior to UV exposure, d) TBG post 
UV exposure, e) TBG incorporated into Encapso® K rubber prior to UV exposure, f) TBG post UV 
exposure, g) side view of e, and h) side view of f. 
  
Similar to the TBG formulation, the FT formulation was also found to have a delayed linear 
optical response to irradiation. Unlike TBG, FT’s spectral response had three peaks (407 nm, 485 nm, 
and 650 nm). 407 nm is bordering the ultraviolet light absorption wavelength range and therefore cannot 
necessarily be correlated to optical observed color. 485 nm is in the absorbed wavelength range for an 
observed color of yellow/orange, and 650 nm is in the absorbed wavelength range for an observed color 
of green/blue. The calibration curve is plotted below for the spectral peak of 650 nm with a near-linear 
fit with R2 = 0.98 (Figure 11) The error bars in the calibration curve were smaller than the symbols and 
represented the standard deviation of three spectrophotometer readings per sample. 
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Figure 11: Post-irradiation response of FT in solution. a) Pictures of FT irradiated to 0, 5, 10, 20, 
40, and 60 Gy using a Co-60 source immediately post-irradiation, 3 hours post-irradiation, 48 hours 
post-irradiation, and 96 hours post-irradiation. b) Spectral response of FT 96 hours after irradiation. 
c) Calibration curve of FT 96 hours after irradiation at the spectral peak 650 nm. The error bars in 
the calibration curve were smaller than the symbols and represented the standard deviation of three 
spectrophotometer readings per sample. 
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Since FT was found to have a delayed optical response and could not easily be incorporated 
into a gel matrix, it was not further investigated for MR contrast. However, future investigations of FT 
could involve incorporating it into other matrixes as an ultraviolet light dosimeter (Figure 12). 
 
Figure 12: a) FT in solution showing color change from colorless clear to dark green with increasing 
UV exposure, b) FT incorporated into Encapso® K rubber prior to UV exposure, c) FT post UV 
exposure (yellow color change), d) side view of b, and e) side view of c. 
 
Unlike the TBG and FT formulations, the FO formulation was found to give an immediate 
linear optical response post-irradiation up to at least 100 Gy at its spectral peak of 512 nm (Figure 13). 
512 nm is within the absorbed wavelength range for an observed color of red. Since one of polymer 
gel’s main disadvantages was its oxygen dependence, the oxygen dependence of FO was investigated 
along with its dose rate dependence, shelf-life time, and gelatin percentage dependence on sensitivity. 
In order to test oxygen dependence, FO in solution was degassed with N2 for 10 minutes per sample to 
remove dissolved O2 (Figure 14). While the exact concentration of O2 was not measured after degassing, 
the bubbling of a chemically inert gas (such as N2 used in this case) can remove dissolved gases such 
as O2 from solution (degasification is also commonly called sparging in chemistry). After removal of 
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O2, the sensitivity of FO to irradiation was increased about 6.0%. Deoxygenation of PRESAGE® was 
found to increase the sensitivity by approximately 30% whereas deoxygenation of FXG was found to 
decrease the sensitivity [136, 137]. The linearity of the dose response was not affected for FO or for 
PRESAGE® and FXG in the literature. The error bars in the calibration curves in Figure 13 and Figure 
14 represented the standard deviation of spectrophotometer measurements averaged for three cuvettes 
per dose level. 
 
Figure 13: a) Spectral response of FO immediately after irradiation (inset image shows FO before 
irradiation – yellow and after irradiation – red). c) Calibration curve of FO at the spectral peak 650 
nm. The error bars in the calibration curve represented the standard deviation of spectrophotometer 
measurements averaged for three cuvettes per dose level. 
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Figure 14: Oxygen dependence test of FO in solution by O2 degassing with N2 for 10 minutes. a) 
Calibration curves of FO with and without O2 and b) example set-up for degassing with N2 into the 
solution with a vent (actual set-up was covered to prevent light affecting the samples). The error bars 
in the calibration curves represented the standard deviation of spectrophotometer measurements 
averaged for three cuvettes per dose level. 
 
The dose rate dependence of FO was tested using a Co-60 source at different distances from 
the source (Figure 15). The dose rate was approximated relative to distance from the source using the 
inverse square law (dose rate2 = dose rate1 * (distance1/distance2)2), so the dose rate at 100 cm source 
to surface distance (SSD) was 0.64 of the dose rate at 80 cm SSD. The error bars in the calibration 
curves in Figure 15 represented the standard deviation of spectrophotometer measurements averaged 
for three cuvettes per dose level. 
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Figure 15: Dose rate dependence of FO. The error bars in the calibration curve represented the 
standard deviation of spectrophotometer measurements averaged for three cuvettes per dose level. 
 
The shelf-life of FO and its effect on dose response sensitivity was tested in light-tight 
environments both at room temperature (RT) and at 4 ºC (Figure 16). After 1 week of storage, the 
calibration curves after irradiation were 2.3% and 0.8% decreased in slope for RT and 4 ºC, 
respectively, when compared to immediate preparation of FO prior to irradiation. After 2 weeks of 
storage, the calibration curves after irradiation were 4.6% and 2.1% decreased in slope for RT and 4 
ºC, respectively, when compared to immediate preparation of FO prior to irradiation. Future work 
should include batch uncertainties to better quantify the uncertainties in the changes of these calibration 
curves. The calibration curves decreased in slope more for RT than for 4 ºC after both 1 week and 2 
weeks of storage. The calibration curves decreased in slope, regardless of storage temperature, when 
compared to immediate preparation prior to irradiation. 
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Figure 16: a) Calibration curves of FO in solution (no gelatin) after storage at room temperature 
(RT) and 4 ºC (4C) for 1 week compared to immediately prior to irradiation and b) after storage for 2 
weeks. The error bars in the calibration curves represented the standard deviation of 
spectrophotometer measurements averaged for three cuvettes per dose level. 
 
The dependence of sensitivity of FO on gelatin concentration was then investigated between 
1.5 and 5 wt %. Greater gelatin concentrations increased the background OD of samples prior to 
irradiations (Figure 17). The post-irradiation sensitivities were most similar for 1.5 and 2 wt % and for 
3 and 5 wt % gelatin. The overall calibration curve slopes decreased with increasing gelatin 
concentration, which agreed with the literature for FXG [137]. 
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Figure 17: Gelatin percentage dependence on FO sensitivity (inset image shows differences in OD of 
samples prior to irradiations depending on gelatin percentage). The error bars in the calibration 
curves represented the standard deviation of spectrophotometer measurements averaged for three 
cuvettes per dose level. 
 
After characterizing the FO formulation for optical linearity with radiation dose, oxygen 
dependence, dose rate dependence, shelf-life, and gelatin percentage dependence with no effects on the 
linearity of the response for all the above, FO was then imaged with MRI in the MR-Linac. Alongside 
FO, the following combinations were investigated for MR contrast (Table 8). 2,2’-Bipyridine was a 
similar reporter component to o-phenanthroline that also formed complexes with iron(II) resulting in a 
red color post-irradiation. 
Table 8: Iron(III) combinations for investigation in the MR-Linac. 
Iron(III) component Reporter component Name of formulation 
Iron(III) ammonium oxalate trihydrate o-phenanthroline FO 
Iron(III) citrate o-phenanthroline FCO 
Iron(III) ammonium oxalate trihydrate 2,2’-Bipyridine FB 
Iron(III) citrate 2,2’-Bipyridine FCB 
 
However, similar to TBG, FO also did not result in a clearly distinguishable MR signal intensity 
change post-irradiation of approximately 34 Gy (Figure 18). The net percent signal intensity increases 
from the post-irradiation T1-weighted images were 8.8±1%, 11.0±1%, 8.1±1%, and 8.8±2% for a) FO, 
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b) FCO, c) FB, and d) FCB, respectively. Similarly to TBG and FT, future investigations of FO could 
involve incorporating it into other matrixes as an ultraviolet light dosimeter (Figure 19). 
 
 
Figure 18: a) Pictures of physical dosimeters where A – FO, B – FCO, C – FB, and D – FCB. The 
top half of each gel was not irradiated, and the bottom half was irradiated to approximately 34 Gy. b) 
Snapshots of bFFE acquisitions with TR/TE = 5/2.4 ms. c) Post-irradiation acquisitions with TSE 
TR/TE = 500/20 ms. MR images shown with color instead of grayscale to emphasize contrast. 
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Figure 19: a) FO incorporated into Encapso® K rubber prior to UV exposure, b) FO post UV 
exposure (red color change), c) side view of a, and d) side view of b. 
 
2.4 Summary 
 After comparisons of iron(II) and iron(III) formulations optically and with MRI, the iron(II) 
formulation FOX had the greatest optical and MR contrast. FOX changed linearly with respect to dose 
for both optical and MR read-out, both immediately post-irradiation and in real-time during irradiation. 
Whereas iron(III) formulations, such as FO, responded linearly with respect to dose up to at least 100 
Gy, its response could not be accurately measured using MRI at clinically relevant quality assurance 
dose levels. Overall, iron(II) formulations are recommended for MR-IGRT applications, and iron(III) 
formulations are recommended for UV applications (preliminary results shown in Figure 10, Figure 12, 
and Figure 19). Further characterization of FOX is presented in Chapter 3. 
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Chapter 3 – Characterization of optimal radiochromic formulation 
 
3.1 Rationale 
 Following identification of the most ideal candidate gel formulation for MR-IGRT applications 
in Chapter 2, the FOX and a reusable version of FOX (rFOX) formulations were characterized for their 
dose response. Since FOX depends on the oxidation of iron(II) after the radiolysis of water, rFOX was 
created with the addition of a reducing agent. Further explanation on the behavior of rFOX with respect 
to the reducing agent is presented in this chapter. Most importantly, for volumetric dose comparisons 
with planned dose presented in Chapter 5, the linearity of the dose response should be preserved 
regardless of the irradiation scenario to allow for linear scaling of MR signal intensity to relative dose. 
The dose linearity, radiological properties, reproducibility, time stability, energy dependence, 
reusability of rFOX, dose rate dependence, fractionation dependence, gel matrix dependence, and 
diffusion are presented in this chapter. 
 
3.2 Dose linearity 
 As was mentioned in Chapter 2, dose linearity of FOX were important characteristics for 
eventual relative scaled dose comparisons with treatment planning system planned doses. A more 
detailed characterization of the linearity of FOX and rFOX are presented in this chapter. 
 
3.2.1 Optical linearity 
 FOX is linear with radiation dose optically at its spectral peaks of 440 nm and 585 nm up to 
approximately 15 Gy and plateaus above 30 Gy up to at least 100 Gy (Figure 20). The error bars in the 
calibration curves represented the standard deviation of spectrophotometer measurements averaged for 
three cuvettes per dose level. 
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Figure 20: a) Representative absorption spectra of un-irradiated and irradiated FOX, b) un-
irradiated yellow FOX on the left and irradiated purple FOX on the right, c) background subtracted 
spectrum with peaks at 440 nm and 585 nm, d) calibration curve at 440 nm, and e) calibration curve 
at 585 nm. The error bars in the calibration curves represented the standard deviation of 
spectrophotometer measurements averaged for three cuvettes per dose level. 
 
 Initial optical testing for rFOX was conducted using a clinical orthovoltage unit since 
immediate optical readings were not possible using the MR-Linac (and rFOX’s signal decay had not 
yet been carefully investigated for optical read-out). Similarly to previous irradiation using a Co-60 
source, orthovoltage doses were calculated using PDD tables in BJR Supplement 25[138]. Doses up to 
approximately 20 Gy were delivered to rFOX containing different levels of reducing agent (RA) that 
was responsible for making rFOX reusable (1 wt %, 3 wt %, and 5 wt %). The error bars in the 
calibration curves in Figure 21 represented the standard deviation of spectrophotometer measurements 
averaged for three cuvettes per dose level. The RA released iron(III) from its complex with xylenol 
orange and reduced it back to iron(II). For all concentrations of RA, rFOX was linear with respect to 
orthovoltage dose (Figure 21). The sensitivity of rFOX was reduced with increasing concentrations of 
RA. All calibration curve slopes dropped most significantly in the first 24 hours and continued to drop 
close to 0 (indicating the complete reversal of optical signal) up to 96 hours post-irradiation and was 
dependent on RA concentration (faster reversal for higher concentrations of RA). From these results, 
41 
 
 
an RA concentration of 9 wt % were used for larger volumetric rFOX dosimeters to ensure reversal of 
signal by at least 24 hours. 
 
Figure 21: a) Spectral response of rFOX immediately (as realistically possible) after irradiation with 
peaks at 432 nm and 585 nm. Calibration curves at 432 nm b) immediately post-irradiation, d) 24 
hours post-irradiation, f) 48 hours post-irradiation, h) 72 hours post-irradiation, and j) 96 hours 
post-irradiation. Calibration curves at 585 nm c) immediately, e) 24 hours, g) 48 hours, i) 72 hours, 
and k) 96 hours. The error bars in the calibration curves represented the standard deviation of 
spectrophotometer measurements averaged for three cuvettes per dose level. 
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3.2.2 Post-irradiation MR linearity 
 Post-irradiation MR linearity was only measured for rFOX up to approximately 20 Gy with R2 
= 0.99 (Figure 22). The error bars represent the standard deviation from the regions of interest measured 
within the irradiated region in each dosimeter. The raw MR signal intensities are shown in Figure 22 
without subtraction of the 0 Gy sample (so intercept of linear fit is not close to 0). The standard 
deviations of the raw MR signal intensities were on average ±4.8% of the mean raw MR signal intensity. 
 
Figure 22: Post-irradiation MR linearity of rFOX. The error bars represent the standard deviation 
from the regions of interest measured within the irradiated region in each dosimeter. 
 
3.2.3 Real-time MR linearity 
 Real-time MR linearity was measured for FOX and rFOX in the same irradiation set-up and 
bFFE sequence (TR/TE = 5/2.4 ms) with temporal resolution of 275 ms. The real-time MR signal 
intensity was linear with respect to time and dose (constant dose rate delivered) for FOX in gelatin, 
FOX in gelatin and agarose, and rFOX in gelatin and agarose (R2 = 0.82 to 0.87) (Figure 23). The 
relative MR signal intensity was calculated for each dosimeter by dividing all MR signal intensities by 
the un-irradiated MR signal intensity at the start of image acquisition. The error bars represent the 
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propagated standard deviation from the regions of interest measured within the irradiated region and 
outside the irradiated region in each dosimeter. Further results on the real-time MR linearity and bFFE 
sequences will be discussed in Chapter 4. 
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Figure 23: Real-time MR signal intensity linearity with dose for a) FOX in gelatin, b) FOX in gelatin 
and agarose), and c) rFOX in gelatin and agarose. The error bars represent the propagated standard 
deviation from the regions of interest measured within the irradiated region and outside the 
irradiated region in each dosimeter. 
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3.3 Radiological properties 
 The radiological properties and water equivalence of other 3D dosimeters have been presented 
in the past [139–141]. The interaction probability, mass attenuation coefficient ratio, mass energy 
absorption coefficient ratio, mass collision stopping power ratio, and mass radiative stopping power 
ratio were calculated using the National Institute of Standards and Technology (NIST) XCOM (photon 
cross sections database) and NIST ESTAR (stopping power and range tables for electrons) using the 
elemental composition of FOX in comparison with water (Figure 24 and Figure 25). All radiological 
properties demonstrated that FOX was nearly water-equivalent, with interaction probabilities nearly 
overlapping that of water (Figure 24) and ratios within 3.5% of water (Figure 25) 
 
Figure 24: Interaction properties for water and FOX. 
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Figure 25: a) Mass attenuation coefficient ratio, b) mass energy absorption coefficient ratio, and 
stopping power ratios (collisional, radiative, and total) for FOX and water. 
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 The mass attenuation coefficients, mass energy absorption coefficients, and stopping power 
ratios for FOX were calculated by summing the individual values for each element and multiplying by 
their fractional mass (elemental composition by weight fraction given in Figure 24). As mentioned 
above, the elemental coefficients were calculated using the NIST XCOM database. The approximations 
using these calculations were estimated to have a maximum error of 5% [141–144]. FOX has a higher 
mass attenuation coefficient ratio and mass energy absorption coefficient ratio for energies less than 
0.1 MeV due to iron’s photoelectric cross section (Figure 25). Above energies of 0.1 MeV, these ratios 
closely approximate the relative electron density due to the higher interaction probability of Compton 
scatter (or incoherent scatter, which depends on number of electrons) (Figure 24). Similarly, the 
collisional stopping power ratios were approximately the electron density ratios (collisional stopping 
power is proportional to electron density). On the other hand, the radiative stopping power ratios were 
proportional to the atomic number(atomic number + 1). Overall, the radiological properties 
demonstrated that FOX was nearly water-equivalent, with interaction probabilities nearly overlapping 
that of water (Figure 24) and ratios within 3.5% of water (Figure 25) 
 
3.4 Reproducibility 
 For reproducibility testing, intra-batch (within one batch) and inter-batch (between batch) 
variability were tested. For intra-batch variability, the same dose of approximately 4 Gy was delivered 
10 times from one batch in both without and with 1.5 T B0 field present using a Co-60 source. A linear 
fit was applied for intra-batch comparison (a slope of 0 was expected for a zero intra-batch variability). 
For inter-batch variability, the same doses up to approximately 8.2 Gy were delivered to 6 separate 
batches. As expected, the inter-batch variability was greater than the intra-batch variability (Figure 26). 
The linearity of the dose response was preserved across all batches. The error bars in the calibration 
curves represented the standard deviation of spectrophotometer measurements averaged for three 
cuvettes per dose level. The greatest intra-batch variability was 5% measured at 440 nm. The greatest 
inter-batch variability was 10% measured at 440 nm for the calibration slope and 13% measured at 440 
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nm for a single dose point (2 Gy dose point). The greatest intra-batch variability was 4% measured at 
585 nm. The greatest inter-batch variability was 7% measured at 585 nm for the calibration slope and 
7% at 585 nm for a single dose point (8 Gy dose point). 
 
Figure 26: Reproducibility testing for FOX. a) Intra-batch variability with 10 irradiations from one 
batch of approximately 4 Gy (measured at spectral peak of 440 nm), b) intra-batch variability (585 
nm), c) inter-batch variability from 6 batches (440 nm), and d) inter-batch variability (585 nm). The 
error bars in the calibration curves represented the standard deviation of spectrophotometer 
measurements averaged for three cuvettes per dose level. 
 
3.5 Time stability 
 To ensure that repeat measurements for time stability studies were not affected from repeat 
exposure to the xenon lamp in the spectrophotometer for the range of wavelengths relevant for the FO 
gel formulation, which were also in the range of wavelengths used for the FOX gel (Figure 27). With 
repeat exposure to a broad range of wavelengths in the spectrophotometer, conversions of iron ions 
may occur (and appeared to be near-linearly related to the number of exposure, R2 = 0.99). The standard 
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deviation of 30 consecutive spectrophotometer measurements was no more than ±0.5% of the mean 
OD, compared to up to ±10% standard deviation from the mean MR signal. 
 
Figure 27: The effect of repeat spectrophotometer xenon lamp exposures on consecutive optical read-
out of FO gel measured at 512 nm. The center dotted line represents the mean value from the 30 
readings. The surrounding dotted lines show the bounds from the mean value considering the 
standard deviation of the 30 readings. The increase in net OD with repeat exposure to the xenon lamp 
was found to be linear (R2 = 0.987). 
 
To investigate time stability post-irradiation, FOX was irradiated to approximately 4 Gy then 
repeatedly measured for up to 68 days when stored at either room temperature or at 4 ºC with three 
cuvette samples per environment (stored with covers to minimize the evaporation of water) (Figure 28). 
The stability for 4 Gy, 0 Gy, and net 4 Gy (4 Gy – 0 Gy) was best preserved over 68 days when stored 
at 4 ºC and measured at the spectral peak of 440 nm. The stability of FOX when stored at room 
temperature plateaued after irradiation for up to 12 days then changed over the course of 56 days (Figure 
28). Although both room temperature and 4 ºC samples were stored in boxes to prevent stray light 
affecting the samples, it was possible that more stray light reached the room temperature FOX. Also, 
gelatin lost its rigidity over time when stored at room temperature, which would also affect the OD 
values (by affecting the amount of light absorbed, scattered, and transmitted). These results encourage 
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the storage of FOX at 4 ºC. Although the OD values remained fairly stable at 4 ºC storage in cuvettes, 
for volumetric studies, this would not be sufficient for preventing diffusion of the signal, eventually 
distorting the dose distribution. Overall, the OD values were not expected to remain 100% stable for 
any scenario of storage due to spontaneous chemical oxidation of iron(II) to iron(III) over time in the 
presence of dissolved oxygen (the oxidation reaction could not occur in the presence of irradiation if 
oxygen is purged, so this is an unavoidable consequence of Fricke-type gels) [145]. 
 
Figure 28: Time stability of FOX measured for 4 Gy (red triangles), 0 Gy (blue squares), and net 4 
Gy (black diamonds) when stored at a) room temperature (measured at spectral peak 440 nm), b) 
room temperature (585 nm), c) 4 ºC (440 nm), and d) 4 ºC (585 nm). The error bars in the curves 
represented the standard deviation of spectrophotometer measurements averaged for three cuvettes 
per time point and per dose level. 
 
3.6 Energy dependence 
 The energy dependence of FOX was tested using a clinical Varian TrueBeamTM linac with 6 
MV and 18 MV radiation beams, a clinical Elekta Versa HDTM linac with 6 MV and 10 MV radiation 
beams, a 1.25 MeV Co-60 source (1.17 MeV and 1.33 MeV gamma rays), 250 kVp using an 
orthovoltage unit, and a pre-clinical 7 MV Elekta MR-Linac. The percent differences in net OD relative 
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to 7 MV (MR-Linac) were -1±2.5%, +1±2.5%, +2±6.5%, +5±6.5%, +4±6.5%, and -11±6.5% at 440 
nm for 6 MV (Varian), 18 MV (Varian), 6 MV (Versa), 10 MV (Versa), 1.25 MeV (Co-60), and 250 
kVp (Orthovoltage), respectively. The percent differences in net OD relative to 7 MV (MR-Linac) were 
-2±2%, +2±2%, +6±3.5%, +9±3.5%, +8±3.5%, and -10±3.5% at 585 nm for 6 MV (Varian), 18 MV 
(Varian), 6 MV (Versa), 10 MV (Versa), 1.25 MeV (Co-60), and 250 kVp (Orthovoltage), respectively. 
Some differences between machines were due to intra-batch variability (up to 5% at 440 nm and 4% at 
585 nm) and inter-batch variability (up to 13% at 440 nm and 7% at 585 nm across 6 batches for a 
single dose level) (one batch was used for Varian and MR-Linac irradiations, and one batch was used 
for Versa, Co-60, and orthovoltage irradiations). Uncertainties stated above were plus or minus half of 
the maximum variability for intra-batch (Varian and MR-Linac values) and inter-batch (Versa, Co-60, 
and orthovoltage values) irradiations. 
 
Figure 29: Energy dependence of FOX relative to net OD measured for 7 MV (MR-Linac). The error 
bars in the curves represented the standard deviation of spectrophotometer measurements averaged 
for three cuvettes per irradiation. 
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3.7 Reusability 
The reproducibility of the reusable version of FOX, rFOX, was tested with repeat irradiations 
of approximately 10 Gy separated by at least 24 hours between each irradiation (Figure 30). The relative 
net MR signal intensity was calculated as the irradiated region’s signal intensity divided by the un-
irradiated region’s signal intensity for each repeat irradiation. The initial net MR signal intensity 
response was lower when compared to following repeat irradiations due to irradiating the gel while still 
cold, having recently removed it from 4° C storage. Temperature of the gel can affect the overall 
sensitivity to irradiation as well as the weak magnetic interactions affecting temperature-dependent 
magnetic moments [64, 146]. Fluctuations in the relative net signal intensity between repeat irradiations 
may also be due to incomplete reversion of iron(III) to iron(II) inside the gel. Between all repeat 
irradiations, rFOX was stored at room temperature away from bright lights. The real-time response of 
rFOX remained linear throughout these repeat irradiations and will be discussed in further detail in 
Chapter 4. 
 
Figure 30: Reproducibility of net MR signal intensity response shown for rFOX irradiated with 
approximately 10 Gy each time with at least 24 hours separating each repeat irradiation. The relative 
net MR signal intensity was calculated as the irradiated region’s signal intensity divided by the un-
irradiated region’s signal intensity for each repeat irradiation. The error bars represent the 
propagated standard deviation from the regions of interest measured within the irradiated region and 
outside the irradiated region in each dosimeter. 
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3.8 Dose rate dependence 
 Dose rate dependence was tested for FOX and rFOX by changing the gun duty cycle from 
100% down to 50% (Figure 31). Unlike the dose rate dependence tested in Figure 15 of FO using 
different distances from the radiation source, this method of changing the gun duty cycle does not 
change the instantaneous dose rate (amplitude of each pulse). The monitor unit (MU) rate at 100% gun 
duty cycle was roughly 500 MU/min (~500 cGy/min at calibration depth). rFOX was imaged with MR 
using two different sequences: T1 contrast enhancement (CE) and no CE. T1 CE and no CE are Philips-
specific terminology for their 3D fast field echo (FFE) sequences and do not indicate that an MR 
contrast agent was injected. The T1 CE sequences spoiled the transverse magnetization using pulse 
phase cycling of the radiofrequency excitation pulses. Therefore, the no CE images included a mixed 
signal of the free induction decay (FID) and spin echo, and the T1 CE images only contained the FID 
signal. As a result, no CE images contain more overall MR signal and reduced apparent noise (smaller 
standard deviations). The relative values were calculated as the net value divided by the net value at 
100% gun duty cycle. For FOX, the percent differences were -2±2.5% and -1±2.5% at 440 nm and -
1±2% and -0.1±2% at 585 nm for 80% and 50% gun duty cycle, respectively. The uncertainties in the 
percent differences for FOX were half of the maximum uncertainty in intra-batch measurements for 
440 nm (5%) and 585 nm (4%), respectively. For rFOX, the percent differences were 1±4% and 1±5% 
for no CE and 2±12% and 3±11% for T1 CE for 80% and 50% gun duty cycle, respectively. 
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Figure 31: Dose rate dependence of a) FOX and b) rFOX. c) Example MR images of rFOX with no 
CE and T1 CE acquisitions. MR images acquired with no CE were smoother with lower standard 
deviation. The relative values were calculated as the net value divided by the net value at 100% gun 
duty cycle. The error bars in a) represent the standard deviation of spectrophotometer measurements 
averaged for three cuvettes per dose level and b) represent the propagated standard deviation from 
the regions of interest measured within the irradiated region and outside the irradiated region in 
each dosimeter. 
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3.9 Fractionation dependence 
 FOX was tested for fractionation dependence up to a total of 12 Gy: 12 Gy delivered in one 
fraction, 12 Gy delivered in 3 fractions of 4 Gy with no time gap between fractions, and 12 Gy delivered 
in 3 fractions of 4 Gy with 20 minutes between fractions (Figure 32). rFOX was tested for fractionation 
dependence up to a total of 20 Gy: 20 Gy in one fraction, two fractions (10 Gy each), four fractions (5 
Gy each), five fractions (4 Gy each), and ten fractions (2 Gy each) with the same total time of delivery 
for all fractionations (Figure 32). The terminology “fractionation” here does not refer to the 
fractionation scheme of radiation treatment, typically separated by 24 hours. This fractionation was to 
test the dependence on the delivery of multiple separate beams for a given radiation plan. For FOX, the 
percent differences compared to 12 Gy x 1 were -0.4±2.5% and -2±2.5% at 440 nm and -2±2% and -
0.3±2% at 585 nm for 4 Gy x 3 and 4 Gy x 3 (20 min), respectively. The uncertainties in the percent 
differences for FOX were half of the maximum uncertainty in intra-batch measurements for 440 nm 
(5%) and 585 nm (4%), respectively. For rFOX, the percent differences for the calibration curve slopes 
(not plotted in Figure 32) compared to that of 20 Gy x 1 were -6±3%, -2±3%, -2±3%, and -8±3% for 2 
Gy x 10, 4 Gy x 5, 5 Gy x 4, and 10 Gy x 2, respectively, with R2 = 0.99 to 1. Uncertainties for rFOX 
were calculated from the standard deviation of all of the calibration curve slopes and for the calibration 
curve slope including all values. 
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Figure 32: Fractionation dependence of a) FOX and b) rFOX. The relative net OD values were 
calculated as the net value divided by the net value at 12 Gy x 1. The error bars in a) represent the 
standard deviation of spectrophotometer measurements averaged for three cuvettes per irradiation 
and b) represent the standard deviation from the regions of interest measured within the irradiated 
region in each dosimeter (raw MR signal intensity given here). 
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3.10 Gel matrix dependence and diffusion 
The FOX gel formulation was further modified in-house with the addition of a reducing agent 
(9 wt %, water content reduced to ~87 wt %) to produce a reusable gel (rFOX). However, the reducing 
agent in rFOX was also found to affect the rigidity of gelatin, so the gel matrix was changed to 3 wt % 
gelatin and 1 wt % agarose. The FOX gel was created in both 4 wt % gelatin and 3 wt % gelatin and 1 
wt % agarose to compare changes in radiation sensitivity with rFOX in 3 wt % gelatin and 1 wt % 
agarose. All gels were contained in 4.5 cm diameter cylindrical PET plastic containers for irradiation 
and MR imaging. FOX in gelatin and agarose, and rFOX in gelatin and agarose were assessed with 
irradiation of approximately 10 Gy (Figure 33). The net percent signal intensity increases determined 
from the post-irradiation T1-weighted images were 20.5±2%, 26.0±2%, and 21.4±2% for a) FOX in 
gelatin (4 wt %), b) FOX in gelatin (3 wt %) and agarose (1 wt %), and c) rFOX in gelatin (3 wt %) 
and agarose (1 wt %), respectively. Optically, the use of agarose instead of gelatin had previously been 
shown to decrease the sensitivity of FXG [147]. The results of this study indicated that the incorporation 
of agarose with gelatin slightly increased the radiation sensitivity of FOX measured using MRI. 
 
Figure 33: Gel matrix dependence. Post-irradiation T1-weighted images (TR/TE = 500/20 ms) of a) 
FOX in gelatin (4 wt %), b) FOX in gelatin (3 wt %) and agarose (1 wt %), and c) rFOX in gelatin (3 
wt %) and agarose (1 wt %). 
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Diffusion of FOX and rFOX (same samples imaged and shown in Figure 33) were measured 
up to 28 days post-irradiation (Figure 34). As shown in Figure 34, the radiation beam edge regions were 
approximately linear. The change in slopes over time are also listed in Table 9 as well as the percent 
differences in slopes relative to the slope measured at 14 minutes post-irradiation for FOX and 0 
minutes post-irradiation for rFOX in Table 10 since they were difficult to distinguish from Figure 34. 
Overall, the slopes decrease over time. Notably for FOX in gelatin or gelatin and agarose, the overall 
signal also gradually rose due to spontaneous oxidation of FOX at room temperature. On the other 
hand, for rFOX, the overall signal gradually decreased as expected as the signal reverted. The change 
in the irradiated region’s signal for rFOX was shown over time to demonstrate the speed of reversal of 
signal (Figure 35). The first two hours of signal change for rFOX were found to be linear and are 
recommended for volumetric relative dose measurements (Figure 35). 
59 
 
 
 
Figure 34: Diffusion of signal for a) FOX in gelatin, b) FOX in gelatin and agarose, and c) rFOX in 
gelatin and agarose for up to 28 days. 
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Table 9: Slopes of radiation field edge over time for FOX and rFOX. 
Time FOX 
(gelatin) 
FOX 
(gelatin and agarose) 
rFOX 
(gelatin and agarose) 
0 min 9.85 6.28 6.08 
14 min 13.41 10.64 6.25 
20 min 14.26 10.51 7.38 
26 min 13.25 10.44 5.04 
30 min 14.13 11.77 4.64 
40 min 14.47 11.87 4.80 
50 min 14.00 11.97 5.30 
1 hr 13.73 10.77 6.01 
1 hr 20 min 16.08 10.38 5.15 
1 hr 40 min 12.86 9.90 4.18 
2 hr 12.18 10.73 1.81 
4 hr 30 min 9.63 5.67 1.57 
5 hr 8.22 5.60 1.70 
24 hr 6.39 4.44 -0.53 
48 hr 5.16 4.22 -0.05 
5 days 3.34 1.99 -0.03 
28 days 3.42 2.79 -0.55 
 
Table 10: Percent differences in slopes of radiation field edge over time for FOX and rFOX relative 
to slope measured at 14 min post-irradiation for FOX and 0 min post-irradiation for rFOX. 
Time FOX 
(gelatin) 
FOX 
(gelatin and agarose) 
rFOX 
(gelatin and agarose) 
0 min -26.5% -41.0% 0.0% 
14 min 0.0% 0.0% 2.8% 
20 min 6.3% -1.2% 21.4% 
26 min -1.2% -1.9% -17.1% 
30 min 5.4% 10.6% -23.7% 
40 min 7.9% 11.6% -21.1% 
50 min 4.4% 12.5% -12.8% 
1 hr 2.4% 1.2% -1.2% 
1 hr 20 min 19.9% -2.4% -15.3% 
1 hr 40 min -4.1% -7.0% -31.3% 
2 hr -9.2% 0.8% -70.2% 
4 hr 30 min -28.2% -46.7% -74.2% 
5 hr -38.7% -47.4% -72.0% 
24 hr -52.3% -58.3% -108.7% 
48 hr -61.5% -60.3% -100.8% 
5 days -75.1% -81.3% -100.5% 
28 days -74.5% -73.8% -109.0% 
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Figure 35: rFOX reversal of raw MR signal intensity. a) Change in signal up to 28 days and b) 
zoomed in view to first 24 hours. The decrease in signal in the first two hours was found to be linear. 
The error bars represent the standard deviation from the regions of interest measured within the 
irradiated region at each time point. 
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Other gel matrixes were tested for FOX but resulted in oxidation of iron(II) during the curing 
process, did not cure, or resulted in no optical or MR visible changes after irradiation (Table 11). For 
non-water based matrixes, a variety of solvents and surfactants were tested: chloroform, acetone, Triton 
X-100, ethanol, and methanol. All tested gel matrixes were optically clear materials on their own. 
Table 11: Gel matrixes tested for FOX formulation. 
Name of matrix Type of matrix Reason(s) for failure 
Encapso® K Encapsulation rubber Oxidation, did not cure 
SS-5060 Silicone No change post-irradiation 
QSil 216 Silicone Oxidation, did not cure 
Sylgard® 184 Silicone Did not cure 
Clear Flex 30 Urethane rubber No change post-irradiation 
Crystal Clear 202 Urethane resin No change post-irradiation 
Crystal Clear 206 Urethane resin Oxidation 
Epoxy Hydrogel Hydrogel No change post-irradiation 
Sodium polyacrylate Super-absorbing polymer No change post-irradiation 
Xanthan gum Polysaccharide polymer Did not gel firmly 
Gellan gum (Phytagel) Polysaccharide polymer Did not gel firmly 
 
3.11 Summary 
The dose linearity, radiological properties, reproducibility, time stability, energy dependence, 
reusability of rFOX, dose rate dependence, fractionation dependence, gel matrix dependence, and 
diffusion were investigated for FOX and rFOX. Both FOX and rFOX were found to be linear with 
respect to radiation dose optically and with MR. Radiological properties of FOX demonstrated that it 
was nearly water-equivalent. The intra-batch and inter-batch variabilities were quantified (up to 5% 
intra-batch and up to 13% inter-batch) to demonstrate the reproducibility of FOX, which can be affected 
by batch-to-batch differences in concentrations of chemicals due to scale and human uncertainties. The 
time stability of FOX was most ideal when stored at 4 ºC. Up to 11±6.5% energy dependence, up to 
3±11% dose rate dependence, and up to 8±3% fractionation dependence were found for FOX and rFOX 
for energies and doses relevant for the MR-Linac. The reusability of rFOX was also demonstrated over 
repeated irradiations of rFOX separated by at least 24 hours. The addition of agarose to FOX increased 
it MR signal intensity change post-irradiation by 27% compared to gelatin alone. The change in MR 
signal intensity for rFOX was -18% compared to FOX in gelatin and agarose (same gel matrix as 
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rFOX). Within the first hour of measurement, changes in the slope at the radiation field edge due to 
diffusion (as well as iron(III) reversal for rFOX) were less than 8% for FOX (gelatin), 13% for FOX 
(gelatin and agarose), and 24% for rFOX (gelatin and agarose). One hour is within the timescale of 
MR-Linac irradiations and immediate post-irradiation imaging. The decrease in MR signal intensity for 
rFOX (correlating to the reversal of iron(III) to iron(II)) was linear within the first two hours (R2 = 
0.99). Indicating that the linear scaling of MR signal intensity from T1-weighted MR images to relative 
dose can reliably be calculated for rFOX within the first two hours of measurement (disregarding 
diffusion and only considering the fading of the MR signal intensity). 
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Chapter 4 – Magnetic field effects on volumetric dosimeters 
 
4.1 Rationale 
 The perpendicular orientation of the strong magnetic field (B0) with respect to the radiation 
beam in systems integrating an MRI with a linac or Co-60 unit influences secondary electrons resulting 
in changes in dose deposition in three dimensions [56, 57]. However, conventional quality assurance 
(QA) tools lack the ability to report changes in volumetric dose distributions and discrepancies out of 
the plane of measurement [85, 148]. Conventional QA tools such as ionization chambers, film, and 
other detectors also exhibit varying degrees of B0 field dependence [55, 57, 116, 149–155]. The effect 
of B0 field on newer detectors, such as plastic scintillators, have also been recently investigated due to 
the growing interest in applying such detectors for MR-IGRT applications [156–158]. To meet the need 
for volumetric and potentially B0 field-independent dose evaluations, several 3D dosimeter types have 
been applied to MR-IGRT systems to assess the electron return effect, B0 field effects on the radiation 
field penumbra, and the feasibility of 3D dosimeters for assessing treatment planning system (TPS) 
calculations and treatment plan deliveries [108, 114–116, 121, 124–126]. Prior to full volumetric dose 
distribution analysis using 3D dosimeters, it was necessary to investigate whether the presence of a B0 
field and gradient/radiofrequency fields present during MR imaging would require correction factors 
to be applied for MR-IGRT applications. Other MR imaging considerations that could impact 
calculated dose distributions were also discussed (these MR considerations are relevant to any MRI 
system and not specific to the MR-Linac). 
 
4.2 Strong magnetic field dependence 
To reduce variability due to inter-batch and day-to-day differences, an electromagnet (GMW 
Dipole Electromagnet Model #3472-70, GMW, San Carlos, CA, USA) was used for same-day 
irradiations with and without a B0 field for all dosimeters (Figure 36). The B0 field strength inside the 
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electromagnet was measured using a gaussmeter at the beginning and end of each set of irradiations 
(Gaussmeter Model GM2, AlphaLab, Inc., Salt Lake City, UT, USA). A B0 field of 1.5 T with 50 mm 
pole caps was used for FOX. FOX dosimeters were positioned consistently inside an acrylic phantom 
(80 cm SSD at the surface of the phantom) and were irradiated with a 5 x 13 cm2 field using a Co-60 
source. The distance between the pole caps with the acrylic phantom between the pole caps was 
approximately 3 cm. The acrylic phantom served as a scatter medium providing 5 cm of build-up and 
5 cm of backscatter material for the dosimeters. The cuvette insert dimensions inside the acrylic 
phantom were 12.5 x 12.5 mm2, and the outer dimensions of the cuvettes were 12.5 x 12.5 mm2. This 
resulted in no measurable air gap between the acrylic phantom and cuvette to prevent the presence of 
electron return effects in the dosimeters. The Co-60 doses were calculated accounting for exponential 
decay of the source and PDD using BJR Supplement 25 depending on the SSD, depth of measurement, 
and field size [128]. 
66 
 
 
 
Figure 36: a) Schematic of electromagnet and location of phantoms when inserted between pole caps 
with the directions of the B0 field and radiation beam noted; b) acrylic phantoms with cuvette inserts 
used for FOX irradiations (sample cuvette in insert). Black dots in phantom and in sample cuvette 
indicate region of optical measurement using a spectrophotometer in relation to the radiation field 
(shaded region); and c) profile of 1.5 T B0 field strength in between pole faces (50 mm) of 
electromagnet. The error bars represent the standard deviation from three readings of the B0 field 
strength. 
 
FOX dosimeters were measured at spectral peaks of 440 nm and 585 nm (Figure 37). The full 
dose calibration curves and each dose level were compared. Percent differences in slope of 1.6±2.5% 
and 0.5±2% were calculated for the full dose curves at 440 nm and 585 nm, respectively. The greatest 
percent difference at a given dose level was 2.3±2.5% at 6 Gy at 440 nm (Figure 37). Because FOX 
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and other iron-based radiochromic gels contain a ferromagnetic iron component, the B0 field effect was 
evaluated for time dependence with FOX dosimeters at the 4 Gy dose point with five different lengths 
of time in the 1.5 T B0 field (0, 6, 7, 10, and 30 minutes) (Figure 37). The percent differences for 
measurements at the spectral peak 440 nm were 1.9±2.5%, 4.1±2.5%, 2.1±2.5%, and 3.3±2.5% for 6, 
7, 10, and 30 minutes when compared to 0 minutes, respectively. Likewise at the spectral peak 585 nm, 
the percent differences were 2.5±2%, -0.9±2%, 2.5±2%, and 0.2±2% for 6, 7, 10, and 30 minutes, 
respectively. The data at neither spectral peak trended with respect to time of exposure to the 1.5 T B0 
field, supporting no significant dependence on the B0 field. 
FOX dosimeters consisted of ferromagnetic iron(II) oxide and polarized oxygen molecules 
with intermediate radicals [63]. While the presence of B0 fields could potentially alter the response and 
sensitivity of iron-based radiochromic gels, I found that this was not the case at 1.5 T with dosimeters 
having been exposed to the B0 field for up to 30 minutes and for doses up to 8 Gy. FOX and other iron-
based radiochromic gels may have B0 field dependence at greater than 1.5 T but this was not tested with 
the electromagnet used for this study or the 1.5 T MR-Linac. 
Although the geometry and beam quality were different, at depths beyond the build-up region 
(5-25 cm), the difference in dose per incident photon with and without a 1.5 T B0 field was on the order 
of 0.5% (lower dose with B0 field beyond build-up region) [55]. For FOX (440 nm), the calibration 
curve slopes decreased in the presence of a B0 field. This agreed with the literature for findings with 
PRESAGE® and with the 0.5% lower dose beyond the build-up region [116, 149, 150]. While 
irradiating in a B0 field shifts the lateral edges of a radiation field, the measurements in this study were 
well within the central region of the radiation field to minimize the contribution of penumbra changes 
in a B0 field [117, 159, 160]. Unlike air-filled ionization chambers, the 3D dosimeters used in this study 
filled their respective containers without the presence of air within the beam’s path. While small air 
gaps between the acrylic phantom and silicone phantom and the 3D dosimeters could result in dose 
enhancement due to the electron return effect, these effects were not within the scope of this study since 
the radiation dose response measurements were averaged over an optical length of 1 cm for FOX [54, 
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161]. Air cavities purposefully incorporated into PRESAGE® and FOX dosimeters have demonstrated 
measurements of the electron return effect with good agreement with literature [116, 120]. Considering 
the scale of dose differences beyond the build-up region and potential dose differences due to the 
presence of small air gaps between the dosimeters and phantoms, the percent differences in response 
with and without B0 fields were minimal for FOX [161]. 
 
Figure 37: a) net OD versus dose linear calibration curves without (R2 = 1.00) and with (R2 = 1.00) 
1.5 T B0 field at spectral peak of 440 nm, b) linear calibration curves (R
2 = 1.00) at spectral peak of 
585 nm, and c) net OD for FOX dosimeters at 440 nm and 585 nm for varying lengths of time in the 
1.5 T B0 field during irradiation to 4 Gy absorbed dose. The error bars represented the standard 
deviation of spectrophotometer measurements averaged for three cuvettes per data point. 
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 B0 field dependence was repeated for FOX inside the MR-Linac with 0 T and 1.5 T 
measurements separated by 9 days (1.5 T measurements were collected for the same batch of FOX used 
for 0 T stored at 4 ºC in between irradiations and for a new batch of FOX prepared approximately 24 
hours prior to 1.5 T irradiations) (Figure 38). Similar findings to the electromagnet irradiations were 
found in the MR-Linac (Figure 38). At 440 nm, the calibration curve slopes were different from 0 T by 
2±2.5% for the same batch at 1.5 T and 4±5% for the new batch at 1.5 T. The largest difference between 
a single dose level was 7±6.5% at 2 Gy. At 585 nm, the calibration curve slopes were different from 0 
T by 3±2% for the same batch at 1.5 T and 0±3.5% for the new batch at 1.5 T. The largest difference 
between a single dose level was 8±3.5% at 2 Gy. 
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Figure 38: a) net OD versus dose linear calibration curves without and with 1.5 T B0 field in MR-
Linac at spectral peak of 440 nm and b) linear calibration curves at spectral peak of 585 nm. The 
error bars in the curves represented the standard deviation of spectrophotometer measurements 
averaged for three cuvettes per data point. 
 
4.3 Gradient and radiofrequency field dependence 
For the gradient/radiofrequency (B1/RF) field dependence portion of the study, cuvettes were 
placed inside a high impact polystyrene cuvette insert that was 1.3 cm thick. Water-equivalent plastic 
backscatter material of 13.2 cm and build-up water-equivalent plastic of 6 cm were placed underneath 
and above the cuvette insert plate, respectively. The cuvettes were irradiated with the same 10x10 cm2 
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field and approximately 4 Gy for each B1/RF field scenario. The cuvettes were irradiated with 4 
different real-time imaging sequences: (1) no imaging during irradiation, (2) TR/TE = 8/3.6 ms, B1 = 
20 µT, maximum gradient mode, dB/dt = 20.5 T/s, (3) TR/TE = 8/3.6 ms, B1 = 20 µT, regular gradient 
mode, dB/dt = 7.3 T/s, and (4) TR/TE = 8/3.6 ms, B1 = 3 µT, maximum gradient mode, dB/dt = 14.0 
T/s (Figure 39). All real-time acquisitions had temporal resolutions of 400 ms. Relative to no real-time 
MRI during irradiation (only B0 field present), the relative net OD was different by -1±2.5% for 
scenario (2), -1±2.5% for (3), and -1±2.5% for (4) at 440 nm and by -1±2% for scenario (2), -1±2% for 
(3), and -2±2% for (4) at 585 nm. 
 
Figure 39: Assessment of potential B1/RF dependence on FOX gel using 4 different real-time bFFE 
sequences at both 440 nm and 585 nm optical peaks: A) no real-time MRI during irradiation, B) 
TR/TE = 8/3.6 ms, B1 = 20 µT, maximum gradient mode, dB/dt = 20.5 T/s, C) TR/TE = 8/3.6 ms, B1 
= 20 µT, regular gradient mode, dB/dt = 7.3 T/s, and D) TR/TE = 8/3.6 ms, B1 = 3 µT, maximum 
gradient mode, dB/dt = 14.0 T/s. Values for B, C, and D were normalized to A for both wavelengths. 
All real-time acquisitions had temporal resolutions of 400 ms. The error bars represented the 
standard deviation of spectrophotometer measurements averaged for three cuvettes per data point. 
 
4.4 Other MR considerations 
Real-time plots of MR signal intensity change previously shown demonstrated that after the 
radiation beam was turned off, the signal continued to drift upwards, with lower slope. Since bFFE 
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images produce more banding artifacts (or Gibbs ringing artifacts) than post-irradiation T1-weighted 
images, the effect of the number of signal averages (NSA, also known as number of excitations NEX) 
on the MR signal intensity was investigated (Figure 40). The temporal resolutions for NSA of 1, 2, 3, 
and 4 were 231 ms, 476 ms, 710 ms, and 947 ms, respectively. NSA and its effect on banding artifact 
on the real-time bFFE acquisition was assessed using only the rFOX gel with TR/TE = 3.8/1.92 ms for 
all NSA. Gibbs ringing artifacts are deterministic and could be reduced but could never be completely 
removed due to arising from the fundamental consequence of using Fourier transform to reconstruct 
MR signals into images (Figure 47). 
The standard deviation for the real-time relative MR signal intensity decreased with increasing 
NSA (average standard deviation of 0.057, 0.033, 0.027, 0.024 for NSA = 1, 2, 3, and 4, respectively) 
(Figure 40). However, the temporal resolution worsened with increasing NSA (the time for MR image 
acquisition increases linearly with increasing NSA). The benefit of increasing NSA seemed to diminish 
for NSA > 3. The linear fit was no longer improved for NSA = 4 and the signal within the irradiated 
region began to decrease slightly during acquisition post-irradiation. The stability of the acquisition 
pre-irradiation and post-irradiation was further investigated using NSA = 2 up to 10 minutes pre-
irradiation and 20 minutes post-irradiation (Figure 41). While the MR signal intensity gradually drifts 
downward prior to irradiation, the MR signal intensity remains relatively stable post-irradiation for up 
to 20 minutes (Figure 41). 
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Figure 40: Real-time relative MR signal intensity for a) NSA = 1, b) NSA = 2, c) NSA = 3, and d) 
NSA = 4. The temporal resolution for NSA = 1, 2, 3, and 4 were 231 ms, 476 ms, 710 ms, and 947 ms, 
respectively. The orange shaded regions indicate beam on times. The red lines indicate the relative 
MR signal intensity in the irradiated region and the blue lines show the intensity in the un-irradiated 
region. The error bars represent the propagated standard deviation from the regions of interest 
measured within the irradiated region and outside the irradiated region in each dosimeter. 
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Figure 41: Real-time relative MR signal intensity for NSA = 2 with temporal resolution of 476 ms 
demonstrating stability of signal intensity pre-irradiation and post-irradiation for up to 10 minutes 
and 20 minutes, respectively. The orange shaded region indicates beam-on time. The error bars 
represent the propagated standard deviation from the regions of interest measured within the 
irradiated region and outside the irradiated region in each dosimeter. 
 
A 3D dose distribution was acquired by irradiating a FOX gel with two gantry angles (0° and 
270°). The two beams were separated by approximately 24 seconds, including time for gantry rotation. 
A central slice was imaged during irradiation to confirm the linear increase in MR signal intensity with 
time (and dose with constant rate of approximately 540 ± 10 cGy/minute). The regions of interest within 
and outside the beam path and change in MR signal intensity are also shown. Quantification of regions 
of interest within the central slice demonstrate that the gel again responded linearly with time (and dose 
with a constant dose rate) (R2 = 0.98 and 0.99). Volumetric snapshots for the FOX gel are shown below. 
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Figure 42: FOX gel used for 3D dose acquisition in an 85 mm diameter and 60 mm tall PET 
container. Post-irradiated T1-weighted images are shown to the right of the physical dosimeter 
(irradiated and imaged in MR-Linac). 
 
 
Figure 43: Real-time snapshot of FOX gel showing regions of interest used to assess un-irradiated 
and irradiated regions. Images were acquired using a bFFE sequence of TR/TE = 4.4/2.2 ms with 12 
slices per acquisition, NSA = 1, and temporal resolution of 1800 ms. The red line indicates the 
relative MR signal intensity in the irradiated region and the blue line shows the signal in the un-
irradiated region. The error bars represent the propagated standard deviation from the regions of 
interest measured within the irradiated region and outside the irradiated region. 
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Figure 44: Real-time volumetric snapshots of FOX gel after irradiating to approximately a) 0 Gy, b) 
5 Gy, c) 10 Gy, d) 15 Gy, e) 20 Gy, f) 25 Gy, and g) 30 Gy delivered to the center of the gel. The first 
10 Gy were delivered with gantry angle 0° and the last 20 Gy with gantry angle 270°. 
 
 The volume dependence of FOX was investigated using 16 oz, 12 oz, and 4 oz PET containers 
irradiated to the same doses. The percent increase in MR signal intensity post-irradiation was 26.7±3%, 
27.4±2%, and 26.1±2% for 16 oz, 12 oz, and 4 oz FOX, respectively (Figure 45). These MR images 
were acquired with TR/TE = 500/20 ms, turbo spin echo (TSE), and with reconstructed voxels of 0.35 
x 0.35 x 3.00 mm3. 
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Figure 45: a) MR images of FOX gels in 16 oz, 12 oz, and 4 oz containers pre-irradiation and post-
irradiation and b) MR signal intensities of those images. The error bars represent the standard 
deviation from the regions of interest measured within the pre-irradiated and post-irradiated regions 
in each dosimeter. 
  
The MR images of FOX were also tested for gantry angle dependence since imaging could be 
acquired at arbitrary gantry angle during and after plan delivery in Chapter 5. Gantry angles 0º, 90º, 
180º, and 270º were investigated (Figure 46). These MR images were acquired with TR/TE = 11/4.6 
ms, T1 CE 3D FFE, and with reconstructed voxels of 0.83 x 0.83 x 1.00 mm3. The percent MR signal 
intensity increases were 42.3±3%, 43.1±3%, 42.8±3%, and 40.7±3% for gantry angles 0º, 90º, 180º, 
and 270º, respectively. 
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Figure 46: a) MR images of FOX gels for gantry angles 0º, 90º, 180º, and 270º pre-irradiation and 
post-irradiation and b) MR signal intensities of those images. The error bars represent the standard 
deviation from the regions of interest measured within the pre-irradiated and post-irradiated regions 
in each dosimeter. 
 
 MR-sequence specific artifacts included fold-over artifacts, Gibbs ringing artifacts at 
interfaces, zipper artifacts from PET plastic, and artifacts from super glue. These artifacts would arise 
regardless of the MRI system and were not specific to the MR-Linac. Examples of such artifacts are 
shown below in Figure 47. The presence of such artifacts could result in mis-analysis of dose when 
converting the MR images to relative doses. Fold-over artifacts could be mitigated by increasing the 
fold over suppression oversampling or by increasing the field of view acquired. Gibbs ringing artifacts 
could be reduced in the gel on the right of Figure 47b but could never be completely removed due to 
arising from the fundamental consequence of using Fourier transform of a truncated sync function to 
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reconstruct MR signals into images. Zipper artifacts that generally occur with radiofrequency 
contamination from electronic devices occurred with spin echo sequences in PET plastic (with gel or 
water) but could be removed with a turbo spin echo sequence. The presence of super glue resulted in 
an MR signal void (whether the jar was filled with gel or water) but was not true with the use of hot 
glue. The main component of super glue is ethyl cyanoacrylate or another cyanoacrylate ester, which 
consists of carbon, hydrogen, nitrogen, and oxygen. The MR signal void was most likely due to a 
proprietary metal component that was not indicated in any technical data sheets. 
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Figure 47: Examples of MRI artifacts. a) Fold over artifacts that could be remedied with suppression 
oversampling or increased field of view, b) Gibbs ringing artifact that could be reduced in the gel on 
the right but could never be completely removed due to arising from the fundamental consequence of 
using Fourier transform to reconstruct MR signals into images, c) zipper artifact that generally 
occurs with radiofrequency contamination from electronic devices occurred with spin echo sequences 
in PET plastic (with gel or water) and remedied on the right with a turbo spin echo sequence, and d) 
MR artifact due to super glue on bottom of jar (regardless of gel or water) but not present when hot 
glue was used. Central black region was due to brass ball bearing. 
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4.5 Summary 
 This chapter investigated MR-related considerations for volumetric dosimetry using MR 
images including B0 field dependence, B1/RF field dependence, and potentials for MRI artifacts. 
Overall FOX was found to have up to 4±5% B0 field dependence and up to 2±2% B1/RF field 
dependence. The real-time MR signal intensity change with radiation dose remained linear for FOX 
and rFOX regardless of the real-time bFFE sequence used. Example MRI artifacts that could affect the 
conversion of MR signal intensities scaled to relative volumetric dose distributions were also discussed 
for fold-over artifacts, Gibbs ringing artifacts at interfaces, zipper artifacts from PET plastic, and 
artifacts from super glue. 
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Chapter 5 – Volumetric phantom study 
 
5.1 Rationale 
 MR-IGRT systems require a modified clinical workflow to integrate MR images for daily 
adaptive re-planning. Conventional treatment plan delivery checks are conducted using quasi-3D arrays 
such as the ArcCHECK or with 2D arrays. These are valuable clinical tools for quality assurance since 
they are not time consuming to set-up and take measurements from (compared to having to process and 
scan film for planar measurements). Dosimetry panels such as the IC Profiler (Sun Nuclear) and 
Starcheck (PTW) allow for measurements in two perpendicular profiles and two diagonal profiles. The 
detectors for these devices are distributed evenly over a surface. Investigations on the use of such 
devices in a B0 field have been done [151, 153, 162]. The IC Profiler consists of 251 parallel plate 
ionization chambers (0.05 cm3 sensitive volume per chamber) in its panel, with intrinsic build-up of 0.9 
g/cm2 and backscatter of 2.3 g/cm2. A 1.5 T B0 field was found to affect the IC Profiler’s profile 
measurements, but normalization profiles were comparable with that of film [151, 153]. The Starcheck 
consists of 527 vented ionization chambers, again in two perpendicular profiles and two diagonal 
profiles. The reference detector at the center position of the Starcheck was not always in the same 
orientation of nearby detectors, depending on the profile measured, resulting in a discontinuity in the 
profile [151, 153]. Similar to the IC Profiler, care must be taken when normalizing the Starcheck 
ionization chamber measurement values. Quasi-3D arrays such as the ArcCHECK (Sun Nuclear) and 
Delta-4 (Scandidos) have also been investigated in a B0 field [151, 153, 163, 164]. The ArcCHECK is 
a cylindrical water-equivalent phantom consisting of an array of diodes near its perimeter with a 15 cm 
wide center cavity (with an assortment of available plugs, including a plug for ionization chamber 
reference dosimetry). The performance of the ArcCHECK in the 1.5 T MR-Linac was found to be 
within 1% of its performance in a conventional linac [151, 153]. The Delta-4 is not yet commercially 
available as an MR-compatible device. However, these devices cannot be MR imaged nor would they 
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provide valuable MRI information. Ideally, a fully anthropomorphic MR-visible and radiation-sensitive 
phantom would be used for a complete end-to-end clinical workflow assessment. While commissioning 
phantoms including CT and MR-visible materials are currently in development, these depend on point 
and planar measurements using thermoluminescent dosimeters (TLDs) and film, which can miss dose 
information in three dimensions [165, 166]. Compared to 3D gels, the implementation of a phantom 
for multi-institutional and remote dosimetry is of course simplified with a commissioning phantom 
with TLD and film inserts, with the understanding that volumetric dose distributions cannot be 
quantified. Conventional plan verification anthropomorphic phantoms only included planar film and 
point dosimeters (such as TLDs or ion chambers) and generally produced at best poor MR image 
quality. For example, MR imaging of an anthropomorphic Rando phantom required placing an MR-
bright substance on top of the phantom and MR-visible PinPoint® #128 markers (Beekley Corporation, 
Bristol, CT) to assist with fusion of the MRI with CT (Figure 48). 
 
Figure 48: a) and b) The anthropomorphic Rando phantom imaged in the 1.5 T MR-Linac using the 
following parameters: 300 slices with FOV of 400 x 400 x 300 mm3, reconstructed voxel 0.83 x 0.83 x 
1 mm3, T1-weighted TR/TE = 11/4.6 ms, 3D FFE, and 30° flip angle. c) and d) CT of same phantom. 
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 To fill the need for a large volumetric, MR-visible, and radiation-sensitive phantom for end-
to-end assessment of MR-IGRT workflow, I utilized my rFOX and conventional FXG gel formulations 
in both heterogeneous and homogeneous phantom studies. 
 
5.2 Heterogeneous rFOX phantom results and discussion 
 The first investigation of end-to-end testing on the MR-Linac using a volumetric phantom was 
done with a modified IROC-Houston head and neck phantom, commonly used for IMRT plan delivery 
validation, with an rFOX insert (Figure 49). The rFOX gel insert was created with four different 
heterogeneous components and one uniform homogeneous gel insert. The four heterogeneous 
components were a 1.3 cm diameter solution, a 1.3 cm diameter gel, a 1.3 cm diameter air, and a 3 cm 
diameter air (examples of 1.3 cm diameter and 3.0 cm diameter components shown in Figure 49). These 
heterogeneous components were selected to mimic anatomical heterogeneities present in the human 
body that can produce dose perturbations in a strong magnetic field. Relevant examples include tissues 
similar to what was generalized as soft-tissue such as various soft organs and blood vessels (rationale 
for including solution heterogeneity). Other examples include air cavities such as the sinuses and 
trachea (rationale for including air heterogeneities of different sizes). The remainder of the head and 
neck phantom was composed of plastic filled with water. 
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Figure 49: Pictures of head and neck phantom and rFOX inserts. a) rFOX inside of phantom, b) 
rFOX outside of phantom, c) example of 1.3 cm diameter heterogeneous component in rFOX, and d) 
example of 3.0 cm diameter heterogeneous component in rFOX (purple regions were irradiated 
areas). 
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 All of the combinations of rFOX inserts inside the head and neck phantom were initially CT 
scanned with 120 kV, 250 mAs/slice, and 1 mm slice thickness. The CT number to electron density 
(used for dose calculations in treatment planning systems) for 120 kV and the Philips Brilliance Big 
Bore CT scanner are plotted below (Figure 50). The average CT numbers of the rFOX gels, water in 
the phantom, and air were 20.3 ± 9.2, 3.2 ± 7.9, and -1002.6 ± 3.9, respectively. These CT numbers 
could then be used to calculate the linear attenuation coefficient of each material, which was energy 
dependent. The x-ray mass attenuation coefficient of water provided by NIST (µ/ρ) and the density of 
water 1 g/cm3 were used to calculate the linear attenuation coefficients of rFOX and air using the 
equation: µmaterial = (CT number x µwater / 1000) + µwater, where µwater = 0.142 cm-1 for 120 kV. µrFOX and 
µair were calculated to be 0.145 cm-1 and 0.00036 cm-1, respectively, under these conditions. The 
electron densities for all materials were calculated within Monaco TPS. 
 
Figure 50: CT number to electron density conversion. 
 
Reference plans were made in the Monaco TPS (research version 5.19.02) using the CT images 
acquired of the rFOX inserts in the head and neck phantom. Complete cross-validation of the Monaco 
TPS in a B0 field environment had not yet been done at the time of this dissertation work, so some 
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uncertainties in dose are expected as a result (conventional TPS calculations include up to 3% dose 
uncertainties in clinical use due to many different factors, including conversions of CT numbers to 
electron density for dose calculations). Monaco TPS used Monte Carlo dose calculations in a graphical 
processing unit environment that incorporated a 1.5 T B0 field. Daily T2-weighted, T1-weighted T1 
CE, and T1-weighted no CE MR images were acquired for fusion with the CT to create the daily 
adapted plan based on the phantom position in the MR-Linac. These daily adapted plans were then 
delivered in the MR-Linac and post-irradiation MR images were acquired of the gels in the same 
position. Prior to MR-IGRT systems, it was not possible to pre-scan, irradiate, and post-scan 3D 
dosimeters all in the same position. With the MR-Linac and other MR-IGRT systems, we now have the 
ability for delivering a treatment plan to a 3D dosimeter in the exact position that it was planned for 
with the possibility for real-time onboard MR imaging during irradiation and immediate MR imaging 
post-irradiation. The overall MR-IGRT workflow is shown below (Figure 51). 
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Figure 51: Overall MR-Linac workflow. First, make a reference TPS plan from the CT. Next, fuse the 
daily MRI with the CT and make an adapted plan. Next, deliver this plan and obtain a post-
irradiation MRI. Finally, compare the relative delivered dose with the planned dose. 
 
 Small differences (<0.3 mm) in fusion coordinates were found depending on the MR image 
sequence used (T2-weighted, T1-weighted T1 CE, and T1-weighted no CE) (Table 12). Overall, T2-
weighted MR images were not recommended for fusion with CT due to greater distortions at interfaces, 
distorting the geometric accuracies of sharp edges in the images (Figure 52). No differences in fusion 
coordinates were found for MR images acquired at different gantry angles (Table 12), which agreed 
with previous results of investigating MR signal intensities at different gantry angles (Figure 46). MR 
images acquired with T1-weighted no CE were used for all fusion for adapted plans due to its superior 
visibility of edges and reduced noise compared to T2-weighted and T1-weighted T1 CE (Figure 52). 
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Table 12: Fusion translation coordinates for MRI with CT. 
MRI sequence type Gantry angle x (cm) y (cm) z (cm) 
T2-weighted 0º -0.0595 -49.2979 -8.1302 
T1-weighted T1 CE 0º -0.0595 -49.2979 -8.1591 
T1-weighted no CE 0º -0.0695 -49.2879 -8.1591 
T1-weighted no CE 90º -0.0695 -49.2879 -8.1591 
T1-weighted no CE 180º -0.0695 -49.2879 -8.1591 
T1-weighted no CE 270º -0.0695 -49.2879 -8.1591 
 
 
Figure 52: a) T2-weighted MRI, b) T1-weighted T1CE MRI, and c) T1-weighted no CE MRI. 
 
Regardless of the NSA used for a given MRI acquisition, T2-weighted sequences used 3D TSE, 
TR/TE =  1535/278 ms, field of view of 400 x 400 x 300 mm3, and reconstructed voxels of 0.83 x 0.83 
x 1.00 mm3. T2-weighted acquisitions took 1:57 minutes with NSA = 1. T1-weighted T1 CE and T1-
weighted no CE sequences used 3D FFE and TR/TE = 11/4.6 ms with the same field of view and 
reconstructed voxels dimensions as T2-weighted sequences. Both T1 CE and no CE acquisitions took 
1:54 minutes, 5:42 minutes, and 9:29 minutes for NSA = 1, 3, and 5, respectively. 
Due to some initial bugs in Monaco TPS that were addressed after this portion of the study, 
rectangular 3D fields of 4 x 2 cm2 were delivered to the phantom; consequently, the adapted plans did 
not perfectly match the irradiation conditions used so lower agreement between the rFOX calculated 
relative dose and the Monaco TPS calculated dose were expected. 3D fields of 4 x 2 cm2 were delivered 
as 1 beam (gantry angle 0º), 2 beams (0º and 180º), 3 beams (60º, 180º, and 300º), 4 beams (0º, 90º, 
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180º, and 270º), and 7 beams (306º, 255º, 204º, 0º, 51º, 102º, and 153º). After acquisition of the pre-
irradiation and post-irradiation MR images, the relative volumetric dose distributions quantified in the 
gels were compared to Monaco TPS’s calculated doses using 3D Slicer (version 4.6.2) [167, 168]. 3D 
Slicer was an open source software platform that could be used for a wide variety of applications and 
has been validated for TPS plan comparisons using gamma analysis [116, 169]. The 3D Slicer workflow 
is described below. 
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Step 1: Install 3D Slicer software from http://download.slicer.org/ (the latest version available at the 
time of this dissertation work was 4.6.2). 
Step 2: Install the “SlicerRT” extension. 
Step 3: Import dicom files (planned dose, structures, prescan, postscan, and etc.) using the “DICOM 
Browser”. I preferred to use “Add link” rather than “Copy” due to the size of my files. 
Step 4: Load the imported dicom files. If the prescan and postscan were acquired in the same study set, 
load each series separately. If they are loaded at the same time from the same study set, then the values 
will not appear as single scalar values for each, which means the prescan values cannot be subtracted 
from the postscan values. After each piece is loaded, the screen will clear. Click on the “DCM” transfer 
button to load the next series. 
Step 5: Double check that everything was loaded by going to “Subject Hierarchy” (Figure 53). 
 
Figure 53: “Subject Hierarchy” in 3D Slicer. 
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Step 6: Go to “Subtract Scalar Volumes”. Select your postscan for “Input Volume 1” and prescan for 
“Input Volume 2”, enter new output volume name, and click “Apply”. Wait until “Status: Completed” 
(Figure 54). 
 
Figure 54: “Subtract Scalar Volumes” in 3D Slicer. 
 
Step 7: Go to “Transforms” to align your MRI volumes with your plan volumes (based on CT 
coordinates). Depending on the coordinate systems of your MRI, CT and TPS, you may need to press 
“Identity” or the image planes may be mismatched (for example, the sagittal plane will appear in the 
axial plane and rotated incorrectly). You can then manually adjust the translation for LR, PA, and IS. 
If using the MR-Linac system for acquiring your MR images and Monaco TPS, you may enter your 
MR-Linac isocenter coordinates from Monaco TPS adapted plan (fusion translation coordinates already 
applied from the daily MR images) as the following into 3D Slicer: X (cm)  –LR (mm) (may or may 
not be +/–LR depending on how the MR images were exported, can be easily checked using the axial 
plane view), Z (cm)  PA (mm), and Y (cm)  IS (mm). After you are satisfied with the transform 
coordinates, go to “Convert”, select a reference volume (any of the MRI volumes), enter a name for the 
“Output Displacement Field”, and press “Apply” (Figure 55). 
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Figure 55: “Transforms” in 3D Slicer. 
 
Step 8: Go to “Simple Filters”. Here you can select any post-processing image filters for denoising 
(such as “MedianImageFilter” and others). Make sure to create a new “Output Volume” name to not 
over-write your currently existing volumes. After creating any new volumes, you will need to go back 
to “Transforms” and push those volumes over to the right side to be transformed. You will also do your 
image scaling to a relative dose here using “ShiftScaleImageFilter”. “Shift” should be used for 
background values first and then “Scale” for the relative dose inside irradiated regions. Make sure to 
reset “Shift” to 0 and “Scale” to 1 after making any changes (and again, you may choose to over-write 
a volume or create a new volume each time and then transform the new volume). In order to know what 
values to enter, you may visualize the planned dose and your gel image as an overlay and see the values 
of each pixel under “Data Probe” (Figure 56). 
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Figure 56: “Simple Filters” in 3D Slicer. 
 
Step 9: Once you have shifted and scaled your desired relative dose volume, go back to “Subject 
Hierarchy” and make sure that this volume is under a study (notepad icon to left of study). If it is not, 
then drag the series under a study (any study). Then right click on the gel series and select “Convert to 
RT dose volume”. The icon to the left of the series should change from a gray cube to a multi-colored 
cube (Figure 57). 
95 
 
 
 
Figure 57: “Subject Hierarchy” to convert to RT dose volume in 3D Slicer. 
 
Step 10: Once you have converted your desired relative dose volumes into RT dose volumes, go to 
“Radiotherapy” then “Dose Comparison”. You may then enter in your 3D gamma criteria and dose 
thresholds. You can select a “Mask structure” to only analyze dose within the gel and not for the entire 
patient structure set. Again, enter in a new volume name for “Gamma volume” to not over-write any 
existing volumes. Once you press “Calculate gamma”, you have your gamma analysis results (Figure 
58)! 
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Figure 58: “Dose Comparison” in 3D Slicer. 
 
Step 11: Helpful shortcuts for manipulating your images are available here: 
https://www.slicer.org/wiki/Documentation/4.4/SlicerApplication/MouseandKeyboardShortcuts. 
 
 Gamma analysis was used for comparison of the two dose distributions in this dissertation work 
(relative dose calculated from MR images of gel and dose calculated from Monaco TPS). Gamma 
analysis was developed by Low et al. to combine comparisons of dose and spatial information [170]. 
The minimum distance from a reference point from the reference dose (calculated from TPS) to the 
measured point of the comparison dose (relative dose calculated from 3D dosimeter) is the gamma 
index. A gamma index greater than 1 indicated a failing value. A gamma criteria of 7%/4mm distance 
to agreement (DTA) was used by IROC for IMRT head and neck plans for 2D gamma analysis of film 
[171]. While 3D dosimetry studies have used other gamma criteria for 3D gamma analysis (which 
added another spatial dimension to 2D gamma analysis), 7%/4mm was used along with stricter gamma 
constraints (5%/3mm and 3%/3mm) as a comparison with passing cutoffs of 80% [170–173]. While 
85% is the typical passing cutoff, up to 5% differences in gamma pass rates were found depending on 
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small changes to scaling for relative doses. As mentioned earlier, lower than normal gamma passing 
rates (and therefore lower agreement between the two dose distributions) were expected for this portion 
of the study due to initial bugs in Monaco TPS not allowing for the full MR-Linac workflow. A 10% 
dose threshold was applied for all of the gamma analysis, regardless of the gamma criteria. Because of 
the standard deviation due to the noise in the MR images (up to ~10% of the mean MR signal intensity), 
it is important to note that there is a risk of voxels passing with 3D gamma analysis using loose criteria 
(such as 7%/4mm used in this dissertation work). However, since the purpose of this development 
project was to demonstrate the proof of concept of the end-to-end testing workflow using a 3D 
dosimeter and to demonstrate the feasibility of doing so with heterogeneous and homogeneous 3D 
dosimeters, both loose and tighter gamma criteria were used to analysis the relative volumetric dose 
distributions. 
 As mentioned in the 3D Slicer Workflow, several image post-processing tools are built into the 
software, including noise reduction filters, such as the MedianImageFilter and MeanImageFilter. The 
MedianImageFilter (Figure 59) and MeanImageFilter (Figure 60) computed values of each output pixel 
as a statistical median/mean of neighborhood values around a corresponding input pixel. The radius of 
neighborhood pixel values to search can be specified in all three dimensions. While increasing the 
radius of neighborhood pixel values to search improves the smoothness of the image, this could remove 
thin structures and cause blurring of signal, such as in areas with steep dose gradients. Since noise in 
the images were more prevalent in T1-weighted T1 CE images, an analysis of the ideal radius (same 
radius value applied in all three dimensions) to use to post-process T1 CE images with NSA = 1 was 
investigated for only the heterogeneous rFOX phantom with 1.3 cm solution insert for 1 beam delivery. 
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Figure 59: a) Planned dose overlaid on CT image, b) calculated relative dose from rFOX (T1 CE, 
NSA = 1) with no post-processing filter, c) MedianImageFilter radius 1, d) MedianImageFilter 
radius 2, e) MedianImageFilter radius 3, f) MedianImageFilter radius 4, and g) MedianImageFilter 
radius 5. The central region of rFOX that appears like a hot spot is due to the heterogeneous 
component and was not used for dose comparisons since that region cannot be scaled appropriately. 
 
 
Figure 60: a) Planned dose overlaid on CT image, b) calculated relative dose from rFOX (T1 CE, 
NSA = 1) with no post-processing filter, c) MeanImageFilter radius 1, d) MeanImageFilter radius 2, 
e) MeanImageFilter radius 3, f) MeanImageFilter radius 4, and g) MeanImageFilter radius 5. The 
central region of rFOX that appears like a hot spot is due to the heterogeneous component and was 
not used for dose comparisons since that region cannot be scaled appropriately. 
 
Table 13: 3D gamma pass rates for heterogeneous rFOX phantom with 1.3 cm solution insert with 
image post-processing. Pass rates above the 80% cutoff are highlighted in green. 
Post-processing Radius (pixel) 7%/4mm 5%/3mm 3%/3mm 
No filter -- 99.39% 86.38% 69.59% 
MedianImageFilter 1 98.30% 87.85% 74.95% 
MedianImageFilter 2 93.28% 78.375% 67.81% 
MedianImageFilter 3 85.09% 66.30% 56.62% 
MedianImageFilter 4 84.78% 70.07% 59.63% 
MedianImageFilter 5 82.37% 69.84% 58.27% 
MeanImageFilter 1 97.94% 87.72% 75.30% 
MeanImageFilter 2 91.16% 77.04% 65.89% 
MeanImageFilter 3 85.71% 70.54% 60.76% 
MeanImageFilter 4 82.67% 65.38% 54.69% 
MeanImageFilter 5 82.04% 64.68% 52.38% 
  
Analysis of post-processing with both the MedianImageFilter (Figure 59) and 
MeanImageFilter (Figure 60) for T1-weighted T1 CE NSA = 1 images showed that the pass rate was 
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similar for no filter and with filters of radius 1 (Table 13). This indicated that careful shifting and scaling 
of the original postscan – prescan images could be used for gamma analysis without any post-
processing. However, the addition of a filter with radius 1 did improve more strict gamma criteria pass 
rates, so the MedianImageFilter with radius 1 was applied for all following T1 CE NSA = 1 images. 
Overall, no CE gamma pass rates were higher than those for T1 CE for tighter gamma criteria even if 
the looser 7%/4mm gamma pass rates were lower by less than 1.5% (could potentially be improved 
with better scaling of relative dose). This indicated that the no CE images resulted in more informative 
relative dose pixels spatially compared to T1 CE, which were noisier. no CE was also more accurate 
with subtracting the prescan from the postscan as can be seen where the heterogeneous region appeared 
black from being completely subtracted (Figure 61d). The 3D gamma pass rates and representative 
images for the rFOX gel are below for 1.3 cm diameter solution heterogeneity (Table 14 and Figure 
61), a 1.3 cm diameter gel heterogeneity (Table 15 and Figure 62), a 1.3 cm diameter air heterogeneity 
(Table 16 and Figure 63), a 3 cm diameter air heterogeneity (Table 17 and Figure 64), and a uniform 
gel (Table 18 and Figure 65). Representative images were shown with 1 beam irradiation for the 1.3 
cm diameter solution insert (Figure 61), 2 beams irradiation for the 1.3 cm diameter gel insert (Figure 
62), 3 beams irradiation for the 1.3 cm diameter air insert (Figure 63), 4 beams irradiation for the 3 cm 
diameter air insert (Figure 64), and 7 beams irradiation for the uniform gel. All gels, regardless of the 
heterogeneous insert, were irradiated with 1 beam, 2 beams, 3 beams, 4 beams, and 7 beams, separated 
by at least 24 hours for the rFOX gel to revert to background levels. Before and after irradiation, all 
rFOX gels were MR imaged with T1-weighted T1 CE and no CE sequences. For all images, the raw 
pre-irradiated images were subtracted from the raw post-irradiated images. This was due to higher MR 
signal intensities closer to the body and anterior coils in the MRI bore (as expected for any MRI system). 
The purpose of subtracting the pre-irradiated images from the post-irradiated images was to mitigate 
the influence of these signal non-uniformities in the MR images. After this subtraction, the T1-weighted 
MR images were then scaled to the Monaco planned doses to obtain a relative volumetric dose 
distribution. For future work, absolute volumetric dose distributions could be calculated from T1-
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weighted MR images or from quantitative T1-mapped MR images from planar and point dosimetry 
values using calibrated film and ionization chamber values. 
 
Table 14: 3D gamma pass rates for heterogeneous rFOX phantom with 1.3 cm solution insert. Pass 
rates above the 80% cutoff are highlighted in green. 
MRI NSA # Beams 7%/4mm 5%/3mm 3%/3mm 
T1 CE 1 1 99.39% 86.38% 69.59% 
T1 CE 1 2 98.09% 79.28% 61.63% 
T1 CE 1 3 97.92% 79.85% 63.10% 
T1 CE 1 4 97.52% 80.56% 64.33% 
T1 CE 1 7 98.30% 79.39% 61.63% 
no CE 1 1 97.97% 87.68% 76.63% 
no CE 1 2 97.48% 84.42% 69.39% 
no CE 1 3 98.06% 80.84% 62.95% 
no CE 1 4 97.52% 87.39% 74.13% 
no CE 1 7 97.41% 77.63% 59.91% 
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Figure 61: a) CT of rFOX with 1.3 cm solution insert, b) T2-weighted image, c) T1-weighted T1 CE 
image, d) T1-weighted no CE image, e) Monaco TPS dose overlaid on CT, f) T2-weighted relative 
dose (non-linear dose so not analyzed with gamma criteria), g) T1 CE relative dose, h) no CE 
relative dose, i) gamma map of T2-weighted dose, j) gamma map of T1 CE dose, and k) gamma map 
of no CE dose. 
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Table 15: 3D gamma pass rates for heterogeneous rFOX phantom with 1.3 cm gel insert. Pass rates 
above the 80% cutoff are highlighted in green. 
MRI NSA # Beams 7%/4mm 5%/3mm 3%/3mm 
T1 CE 1 1 98.15% 85.24% 70.72% 
T1 CE 1 2 96.02% 74.40% 56.87% 
T1 CE 1 3 89.98% 63.57% 47.08% 
T1 CE 1 4 87.71% 57.35% 41.35% 
T1 CE 1 7 94.16% 81.58% 68.69% 
no CE 1 1 97.01% 86.19% 75.51% 
no CE 1 2 96.03% 83.20% 68.41% 
no CE 1 3 92.74% 78.23% 51.06% 
no CE 1 4 97.61% 85.16% 69.82% 
no CE 1 7 98.38% 85.70% 69.74% 
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Figure 62: a) CT of rFOX with 1.3 cm gel insert, b) T1-weighted T1 CE image, c) T1-weighted no CE 
image, d) Monaco TPS dose overlaid on CT, e) T1 CE relative dose, f) no CE relative dose, g) 
gamma map of T1 CE dose, and h) gamma map of no CE dose. 
 
104 
 
 
Table 16: 3D gamma pass rates for heterogeneous rFOX phantom with 1.3 cm air insert. Pass rates 
above the 80% cutoff are highlighted in green. 
MRI NSA # Beams 7%/4mm 5%/3mm 3%/3mm 
T1 CE 1 1 98.57% 86.77% 72.43% 
T1 CE 1 2 97.40% 78.14% 60.53% 
T1 CE 1 3 95.15% 82.13% 68.79% 
T1 CE 1 4 95.62% 76.74% 60.71% 
T1 CE 1 7 92.34% 71.24% 55.52% 
no CE 1 1 96.64% 86.12% 75.30% 
no CE 1 2 96.92% 84.06% 69.62% 
no CE 1 3 99.14% 86.12% 70.11% 
no CE 1 4 98.07% 84.97% 69.66% 
no CE 1 7 98.77% 86.58% 70.86% 
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Figure 63: a) CT of rFOX with 1.3 cm air insert, b) T1-weighted T1 CE image, c) T1-weighted no CE 
image, d) Monaco TPS dose overlaid on CT, e) T1 CE relative dose, f) no CE relative dose, g) 
gamma map of T1 CE dose, and h) gamma map of no CE dose. 
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Table 17: 3D gamma pass rates for heterogeneous rFOX phantom with 3.0 cm air insert. Pass rates 
above the 80% cutoff are highlighted in green. 
MRI NSA # Beams 7%/4mm 5%/3mm 3%/3mm 
T1 CE 1 1 95.39% 77.74% 61.89% 
T1 CE 1 2 95.55% 71.90% 54.13% 
T1 CE 1 3 92.49% 71.86% 58.06% 
T1 CE 1 4 95.04% 75.62% 60.04% 
T1 CE 1 7 91.61% 70.09% 54.51% 
no CE 1 1 94.89% 84.30% 74.91% 
no CE 1 2 95.40% 82.46% 67.78% 
no CE 1 3 99.13% 87.64% 72.43% 
no CE 1 4 98.27% 84.55% 68.43% 
no CE 1 7 97.62% 83.56% 67.20% 
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Figure 64: a) CT of rFOX with 3.0 cm air insert, b) T1-weighted T1 CE image, c) T1-weighted no CE 
image, d) Monaco TPS dose overlaid on CT, e) T1 CE relative dose, f) no CE relative dose, g) 
gamma map of T1 CE dose, and h) gamma map of no CE dose. 
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Table 18: 3D gamma pass rates for homogeneous rFOX phantom. Pass rates above the 80% cutoff 
are highlighted in green. 
MRI NSA # Beams 7%/4mm 5%/3mm 3%/3mm 
T1 CE 1 1 97.61% 83.97% 69.21% 
T1 CE 1 2 96.75% 75.02% 57.31% 
T1 CE 1 3 94.83% 76.94% 62.18% 
T1 CE 1 4 95.07% 77.02% 61.70% 
T1 CE 1 7 93.24% 75.51% 61.13% 
no CE 1 1 95.20% 84.56% 74.11% 
no CE 1 2 96.50% 82.81% 67.96% 
no CE 1 3 98.17% 83.03% 66.43% 
no CE 1 4 97.98% 84.32% 68.73% 
no CE 1 7 97.70% 84.73% 68.90% 
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Figure 65: a) CT of uniform rFOX with no heterogeneous insert, b) T1-weighted T1 CE image, c) T1-
weighted no CE image, d) Monaco TPS dose overlaid on CT, e) T1 CE relative dose, f) no CE 
relative dose, g) gamma map of T1 CE dose, and h) gamma map of no CE dose. 
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 As mentioned earlier in Chapter 3, the T1 CE sequences spoiled the transverse magnetization 
using pulse phase cycling of the radiofrequency excitation pulses. Therefore, the no CE images included 
a mixed signal of the free induction decay (FID) and spin echo, and the T1 CE images only contained 
the FID signal. As a result, no CE images contain more overall MR signal and reduced apparent noise 
(smaller standard deviations). This was evident in the heterogeneous gel results because T1 CE-
calculated relative dose comparisons failed more with tighter gamma criteria (5%/3mm and 3%/3mm) 
compared to no CE 3D gamma pass rates (Table 14, Table 15, Table 16, Table 17, and Table 18). 
Overall, the pass rates between the heterogeneous inserts and the uniform gel were comparable, 
suggesting the validity of Monaco TPS calculations for heterogeneous environments when comparing 
relatively to a scaled dose from T1-weighted MR signal intensities. Future work should include more 
rigorous cross-validation of Monaco TPS with absolute dose calculations. 
 
5.3 Homogeneous FXG phantom and ArcCHECK-MR results and discussion 
 After delivery of 3D plans onto rFOX inside an anthropomorphic head and neck phantom, step-
and-shoot IMRT plans were investigated next based off of TG-119 IMRT Commissioning Tests [174, 
175]. These plans were delivered onto two liter-sized uniform FXG phantoms. Some difficulties with 
using rFOX in large sizes above one liter resulted in the use of the FXG formulation for this proof of 
concept study of delivering TG-119 plans onto volumetric, MR-visible, and radiation-sensitive 
dosimeters. Because rFOX was not stable in just gelatin, agarose was added as a gel matrix component. 
The advantage of the addition of agarose for gel stability was due to its higher melting point and greater 
rigidity; however, in the context of making gels larger than one liter, this higher melting point make it 
more difficult to dissolve the rFOX components in a uniform manner and uniform distribution of the 
formulation during cooling. For these reasons, as an initial proof of concept of using a Fricke-type gel 
for more complex plan assessment, the FXG formulation was used instead. The FXG formulation has 
been fully characterized for dose distribution calculations from both MR signal intensities and from 
quantified T1 or R1 values in the literature [176–181]. Alongside the FXG phantoms, the plans were 
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delivered onto quasi-3D ArcCHECK-MR for comparison. Sun Nuclear provided an MR-compatible 
ArcCHECK-MR for MR-IGRT systems and had been previously investigated for such applications 
[163, 164, 182]. Without the guidance of lasers and a light field and since the ArcCHECK cannot be 
MR imaged, radio-opaque ceramic BB markers were positioned on its isocenter crosshairs to position 
in the MR-Linac using the electronic portal imaging device (EPID) (Figure 66). Although the 
ArcCHECK-MR does not provide a fully 3D dose distribution, it was included in this comparison with 
FXG as a benchmark for acceptable gamma pass rates since the MR-Linac was still a pre-clinical 
system. Most notably, rigorous MLC calibration and MR to MV isocenter registration had not yet been 
completed at the time of this dissertation work, affecting the delivery of IMRT plans and the accuracy 
of adapted plans based on daily MR images. 
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Figure 66: a) and b) Images of ArcCHECK-MR showing locations of radio-opaque ceramic BB 
markers, c) view of BB on EPID with gantry angle at 0º (BB should be in center of field of view if 
positioned correctly, side BBs not visible in this acquisition due to size of EPID field of view), d) view 
of BB on EPID with gantry angle at 90º or 270º (BBs should be centered and overlap if positioned 
correctly), e) example of mis-aligned ArcCHECK-MR with BBs not overlapping, f) CT of BB used for 
initial isocenter positioning in Monaco TPS, and g) CT of BBs on ArcCHECK-MR used for initial 
isocenter positioning in Monaco TPS. 
 
 Similar to the heterogeneous rFOX phantom study, the FXG gel was MR imaged prior to 
irradiation and post-irradiation using T2-weighted, T1-weighted T1 CE, and T1-weighted no CE 
sequences with the same sequence parameters as for rFOX. Contrary to rFOX, the FXG had a greater 
T2-weighted change and an insignificant T1-weighted no CE change (nearly all voxels failed using 
gamma comparison with the Monaco TPS plan) (Figure 71). However, the post-irradiation T2-weighted 
images were not used for dose distribution analysis since previous studies have shown the T2 response 
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to be non-linear with respect to dose [82]. The overall 3D gamma pass rates are listed in Table 19. 
Figures including the CT of large uniform FXG, T1-weighted T1 CE image, Monaco TPS dose overlaid 
on CT, T1 CE relative dose, example gamma map of T1 CE dose, Monaco TPS dose on CT of 
ArcCHECK-MR, and delivered and planned relative dose comparisons are presented below for the AP 
PA plan (Figure 67), MultiTarget plan (Figure 68), Prostate plan (Figure 69), Head/Neck plan (Figure 
70), and C-shape plan (Figure 71). The AP PA plan is a simple rectangular plan that could be delivered 
in the shortest amount of time with only 2 parallel opposing beams (gantry angles 0° and 180°). The 
MultiTarget plan consisted of 7 beams (gantry angles 0°, 50°, 100°, 150°, 210°, 260°, and 310°) and 
dose constraints identified for three cylindrical targets (central, superior, and inferior). The Prostate 
plan consisted of 7 beams (gantry angles 0°, 50°, 100°, 150°, 210°, 260°, and 310°) and dose constraints 
identified for the prostate planning target volume (PTV), rectum, and bladder. The Head/Neck plan 
consisted of 9 beams (gantry angles 0°, 40°, 80°, 120°, 160°, 200°, 240°, 280°, and 320°) and dose 
constraints identified for the head/neck PTV, spinal cord, and parotids. The C-shape plan consisted of 
9 beams (gantry angles 0°, 40°, 80°, 120°, 160°, 200°, 240°, 280°, and 320°) and dose constraints 
identified for the C-shape PTV and core. The MultiTarget plan had a total of 36 segments; the Prostate 
plan had a total of 28 segments; the Head/Neck plan had a total of 65 segments; and the C-shape plan 
had a total of 55 segments. The plans were all delivered as step-and-shoot IMRT plans, so the greater 
the number of segments, the overall time of treatment delivery was also longer. 
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Table 19: 3D gamma pass rates for TG-119 plans. Pass rates above the 80% cutoff are highlighted in 
green. 
 MRI NSA TG-119 Plan 7%/4mm 5%/3mm 3%/3mm 
FXG T1 CE 1 AP PA 98.68% 92.24% 82.01% 
FXG T1 CE 2 AP PA 98.98% 92.65% 81.23% 
FXG T1 CE 3 AP PA 99.06% 94.06% 84.61% 
FXG T1 CE 4 AP PA 99.02% 94.34% 85.92% 
FXG T1 CE 5 AP PA 99.01% 94.07% 85.88% 
Arc-CHECK -------- -- AP PA -------- -------- 100.0% 
FXG T1 CE 1 MultiTarget 96.07% 48.50% 30.62% 
FXG T1 CE 2 MultiTarget 96.15% 46.70% 29.19% 
FXG T1 CE 3 MultiTarget 95.99% 50.07% 31.56% 
FXG T1 CE 4 MultiTarget 96.73% 54.15% 34.87% 
FXG T1 CE 5 MultiTarget 96.38% 56.35% 36.02% 
Arc-CHECK -------- -- MultiTarget -------- -------- 91.6% 
FXG T1 CE 1 Prostate 96.12% 47.16% 29.12% 
FXG T1 CE 2 Prostate 95.57% 42.86% 26.36% 
FXG T1 CE 3 Prostate 97.21% 54.56% 34.87% 
FXG T1 CE 4 Prostate 97.94% 61.04% 39.78% 
Arc-CHECK -------- -- Prostate -------- -------- 94.5% 
FXG T1 CE 1 Head/Neck 94.28% 44.82% 27.56% 
Arc-CHECK -------- -- Head/Neck -------- -------- 93.8% 
FXG T1 CE 1 C-Shape 94.79% 47.94% 29.99% 
Arc-CHECK -------- -- C-Shape -------- -------- 86.8% 
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Figure 67: a) CT of large uniform FXG, b) T1-weighted T1 CE image, c) Monaco TPS dose overlaid 
on CT, d) T1 CE relative dose, e) gamma map of T1 CE dose, f) Monaco TPS dose on CT of 
ArcCHECK-MR, and g) delivered and planned relative dose comparisons for AP PA TG-119 plan. 
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Figure 68: a) CT of large uniform FXG, b) T1-weighted T1 CE image, c) Monaco TPS dose overlaid 
on CT, d) T1 CE relative dose, e) gamma map of T1 CE dose, f) Monaco TPS dose on CT of 
ArcCHECK-MR, and g) delivered and planned relative dose comparisons for MultiTarget TG-119 
plan. 
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Figure 69: a) CT of large uniform FXG, b) T1-weighted T1 CE image, c) Monaco TPS dose overlaid 
on CT, d) T1 CE relative dose, e) gamma map of T1 CE dose, f) Monaco TPS dose on CT of 
ArcCHECK-MR, and g) delivered and planned relative dose comparisons for Prostate TG-119 plan. 
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Figure 70: a) CT of large uniform FXG, b) T1-weighted T1 CE image, c) Monaco TPS dose overlaid 
on CT, d) T1 CE relative dose, e) gamma map of T1 CE dose, f) Monaco TPS dose on CT of 
ArcCHECK-MR, and g) delivered and planned relative dose comparisons for Head/Neck TG-119 
plan. 
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Figure 71: a) CT of large uniform FXG, b) T1-weighted T1 CE image, c) T1-weighted no CE image, 
d) T2-weighted image, e) Monaco TPS dose overlaid on CT, f) T1 CE relative dose, g) no CE relative 
dose, h) T2-weighted relative dose, i) gamma map of T1 CE dose, j) gamma map of no CE dose, k) 
gamma map of T2-weighted dose, l) Monaco TPS dose on CT of ArcCHECK-MR, and m) delivered 
and planned relative dose comparisons for C-Shape TG-119 plan. 
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5.4 Summary 
 This work was the first to use heterogeneous MR-visible and radiation-sensitive 3D dosimeters 
for full end-to-end testing in an MR-IGRT system. All heterogeneous rFOX dosimeters’ relative doses 
passed for gamma criteria of 7%/4mm, more than half passed for 5%/3mm, and none passed for 
3%/3mm. As mentioned previously, the heterogeneous rFOX dosimeter work was completed prior to 
bug fixes in Monaco TPS so the adapted plans were not created and delivered exactly through the 
planned workflow; as a result, lower gamma pass rates were expected. Since heterogeneous phantoms 
were more susceptible to spatial dose accuracy, this work would be beneficial to be repeated once the 
MR-Linac is no longer pre-clinical. However, the 7%/4mm gamma criteria pass rates (>90%) were 
sufficient to demonstrate the proof of concept of using heterogeneous anthropomorphic rFOX 
dosimeters for 3D dose distribution assessment with the MR-IGRT workflow. 
The homogeneous large FXG dosimeters used for TG-119 IMRT plan evaluation passed for all 
7%/4mm gamma criteria. However, compared to the rFOX 3D plan results, the FXG gamma pass rates 
dropped more steeply for 5%/3mm and 3%/3mm for all IMRT plans except for the AP PA plan. This 
rapid drop in gamma pass rates with tighter gamma criteria could be attributed to the longer plan 
delivery times for the complex step-and-shoot IMRT plans compared to the AP PA plan and 3D plans 
used with rFOX. During this time frame, some diffusion of signal may have occurred; a rigorous 
assessment of dose rate dependence, fractionation, and other characteristics was also not completed in 
this dissertation work for FXG. Since the gamma pass rates were above 94% with 7%/4mm gamma 
criteria, it could be assumed that FXG responded linearly with dose for these plans. Future work should 
either utilize fewer control points for the TG-119 plans or incorporate FXG or another formulation into 
a gel matrix that has less diffusion compared to only gelatin. 
The effect of NSA on gamma pass rates was also investigated for the homogeneous large FXG 
dosimeters. NSA = 3 or 4 resulted in the greatest pass rates by up to 1.8% compared to NSA = 1 with 
the MedianImageFilter with radius 1 applied. However, the MRI acquisition time rose linearly with 
NSA (NSA = 3 required 3 x length of time required for NSA = 1). With only an increase in pass rate 
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by up to 1.8% for NSA = 3 or 4, applying post-processing filters to images acquired with NSA = 1 
would be recommended when diffusion was of concern. 
 This work was the first to use a homogeneous MR-visible 3D dosimeter for full end-to-end 
testing in an MR-IGRT system. Previous work used non-MR-visible 3D dosimeters, indicating that the 
clinical adaptive plan workflow could not be used [108]. However, previous work with non-MR-visible 
3D dosimeters did result in higher gamma pass rates with tighter criteria (3%/3mm), those results were 
acquired with optical CT scanning methods that could measure high resolution signal with less noise 
when compared to MRI. The benefit of using an MR-visible 3D dosimeter in this proof of concept was 
to eliminate registration errors between prescans of the dosimeter, delivery of plan based on the 
prescans orientation, and postscans of the dosimeter. The entire clinical workflow including daily MR 
imaging for adaptive planning and all scans of the dosimeters could be completed in one MR-IGRT 
system using an MR-visible 3D dosimeter, eliminating the need for an outside read-out system such as 
an optical CT scanner. However, one advantage of non-MR-visible plastic dosimeters included reduced 
diffusion, resulting in higher gamma pass rates for tighter criteria [108]. 
At the time of this dissertation work, the MR and MV isocenters had not yet been registered, 
the MLCs had not yet undergone a rigorous calibration, and the MR-Linac had not yet been fully 
commissioned and calibrated. For these reasons, the pass rates were not as high as expected for a fully 
clinical system. Updates to the Monaco TPS and workflow were also still underway at the time of this 
dissertation work. Under these limitations, the feasibility of using both heterogeneous and 
homogeneous MR-visible and radiation-sensitive 3D dosimeters were confirmed with encouraging 3D 
pass rates with gamma criteria of 7%/4mm. 
Limitations of using Fricke-type gels, including rFOX and FXG, for volumetric dose 
calculations include noise in the MR images. Reducing MR image noise requires longer scan times (for 
example by acquiring with larger NSA). However, for rFOX, the MR signal intensities were 
continuously dropping post-irradiation, making it difficult to acquire dosimetrically valuable MR 
images with significantly longer scan times (on the scale of hours for a volumetric scan) (Figure 35). 
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For FXG, while the MR signal intensity is not dropping, diffusion of iron ions distort the dose 
distribution on the scale of hours for Fricke-type gels (Figure 34, Table 9, and Table 10). 
  
123 
 
 
Chapter 6 – Conclusion 
 
6.1 Summary and conclusion 
The purpose of this dissertation was to demonstrate the feasibility and benefit of volumetric, 
MR-visible, and radiation-sensitive detectors for MR-IGRT applications. 
In Chapter 2, I investigated candidate volumetric gel formulations, both already presented in 
the literature and novel formulations explored for this dissertation, for dosimetric value on MR-IGRT 
systems. The FOX formulation was found to be the most optimal, both optically and with MRI, for 
MR-IGRT applications (up to 114% greater optical response, 10% greater real-time MR response, and 
46% greater post-irradiation T1-weighted MR response when compared to conventional FXG). I also 
demonstrated for the first time that iron(III) reduction formulations were more sensitive to UV exposure 
compared to megavoltage irradiations, and that iron(II) oxidation formulations were more sensitive to 
megavoltage irradiations than UV exposure [114, 183]. 
In Chapter 3, I presented the characterization of my novel formulations FOX and rFOX. Dose 
linearity, radiological properties, reproducibility, time stability, energy dependence, reusability of a 
formulation, dose rate dependence, fractionation dependence, gel matrix dependence, and diffusion 
were quantified. In all scenarios, FOX and rFOX were found to respond linearly with respect to dose 
in real-time during irradiation and immediately post-irradiation. 
In Chapter 4, I investigated strong magnetic field and gradient field/radiofrequency effects on 
the response of FOX as well as optimization of MR sequences for the purposes of real-time imaging 
during irradiation and immediate post-irradiation imaging for volumetric dose quantification of rFOX. 
Minimal magnetic field and gradient field/radiofrequency field effects were found for FOX. Volume 
dependence and gantry angle dependence were also investigated with minimal effects. Gantry angle 
dependence was a new concept specific to MR-IGRT systems, where the gantry may not necessarily 
be in the same position each time for MR imaging. Other MR considerations that were true for any 
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MRI read-out technique, such as MRI artifacts, were also discussed. I was the first to investigate strong 
magnetic field effects on a radiochromic gel dosimeter and was the first to investigate any gradient 
field/radiofrequency effects on 3D dosimeters. I was also the first to investigate several MR 
considerations specific to and not specific to MR-IGRT systems, such as gantry angle dependence on 
MR imaging and the occurrence and mitigations for MR artifacts, respectively. 
In Chapter 5, I examined the performance of rFOX and FXG as end-to-end quality assurance 
devices both in heterogeneous and homogeneous phantoms for 3D plans and step-and-shoot IMRT 
commissioning plans. TG-119 IMRT plan irradiations were completed alongside the quasi-3D 
ArcCHECK-MR QA system. This work demonstrated the proof of concept of using rFOX and FXG in 
both heterogeneous and homogeneous phantoms for end-to-end assessment of the MR-IGRT workflow 
and relative dose comparisons with the Monaco TPS plan doses. I was the first to investigate 
heterogeneous 3D dosimeters for MR-IGRT applications and the first to use 3D dosimeters as a full 
end-to-end quality assurance tool for MR-IGRT, including adapting plans using daily MR images of 
the dosimeters. Previous work on IMRT plan verification in MR-IGRT systems utilized non-MR-
visible radiochromic plastic dosimeters [108]. Again, limitations of using Fricke-type gels, including 
rFOX and FXG, for volumetric dose calculations include noise in the MR images. Reducing MR image 
noise requires longer scan times (for example by acquiring with larger NSA). However, for rFOX, the 
MR signal intensities were continuously dropping post-irradiation, making it difficult to acquire 
dosimetrically valuable MR images with significantly longer scan times (on the scale of hours for a 
volumetric scan) (Figure 35). For FXG, while the MR signal intensity is not dropping, diffusion of iron 
ions distort the dose distribution on the scale of hours for Fricke-type gels (Figure 34, Table 9, and 
Table 10). 
 
6.3 Future works 
 Future work suggested include further investigations into other matrixes for radiochromic gels 
to allow for their use without a container, to reduce diffusion, or as a deformable gel. A polymer gel 
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based deformable gel was made by encasing in a thin latex material and could easily be translated for 
radiochromic gel work [184–186]. Although my work was the first to demonstrate the proof of concept 
of real-time 3D dose acquisition during irradiation, this work should be continued in a deformable gel 
in a motion phantom [111–114]. There are currently two MRI-compatible motion phantoms available: 
CIRS dynamic phantom and Modus QUASAR respiratory motion phantom. Respiratory motion has 
remained a challenge in radiation therapy for reducing organs at risk dose while maintaining or reducing 
local recurrence [187–189]. Motion phantom studies are necessary for testing translational 
methodologies using MR-IGRT prior to patient treatment. Also of continued interest in the 3D 
dosimetry field is a lung equivalent 3D dosimeter as well as in combination with other materials to 
make realistic heterogeneous phantoms [190–192]. I also encourage further characterization of FOX 
and rFOX along with improved MR sequences for image quality in order to more accurately assess 
IMRT plans with tighter gamma criteria. While long MR imaging sequences were avoided for rFOX 
and FXG due to concerns with signal reversal and signal diffusion for rFOX and FXG, respectively, 
further investigations into the most efficient MR imaging sequence to balance time with image quality 
for volumetric dose distribution evaluation are recommended. This dissertation work investigated 
relative 3D doses for rFOX and FXG; future work could include calibrating the dosimeter for absolute 
3D doses. Suggestions have been made for internal calibrations of 3D dosimeters within a single 
dosimeter for calibration and plan delivery [193]. 
 Overall, this dissertation work encourages further investigations of MR-visible and radiation-
sensitive 3D dosimeters for MR-IGRT applications, both as a general quality assurance tool and as an 
end-to-end test. I have done some initial work on investigating the use of 3D dosimeters for MR-
isocenter and MV-isocenter registration since other current methods lack a technique that is both MR-
visible and radiation-sensitive [119]. During our initial experience with the MR-Linac workflow, it was 
extremely beneficial to have an MR-visible and radiation-sensitive tool for following the workflow 
end-to-end and to visually see where dose was being deposited (both optically and with MR images). 
Especially since MR-IGRT workflows are not the same as conventional linac workflows, I especially 
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encourage the use of 3D dosimeters for initial end-to-end experience before patient treatments are 
delivered. My rFOX dosimeter can be imaged with CT and MRI, used for reference and adapted 
planning practice, tracked with MRI in a motion phantom, can be incorporated into heterogeneous 
anthropomorphic or homogeneous phantoms, irradiated with a plan, its relative 3D dose distribution 
can be compared with the planned dose, and can be reused. 
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